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Abstract
Understanding the effectiveness of a drug therapy on halting disease progression is
an essential aspect of cancer biology. Conventional assays that study cell behavior
after a drug intervention report the average response of a cell population which can
mask the heterogeneity and dynamics of seemingly identical cells. Recently, many
single-cell techniques have been developed, but there are currently no methods that
can fully characterize the long-term effects of drug treatment on cancer cell growth.
To accomplish such, we developed an instrument to measure single-cell growth
before and after drug treatment. In order to achieve femtogram-level mass resolu-
tion, we employed the suspended microchannel resonator (SMR), a vacuum-packaged
cantilever with an embedded channel. Here, we describe three implementations that
involve different technologies (optical trap, mechanical trap, and dynamic flow trap-
ping) to capture a cell for repeated measurements and to perform drug delivery.
Applying the technique we developed based on the dynamic flow trapping, we
were able to monitor one or more generations of a cancer cell before and after drug
treatment. We investigated the growth of mouse leukemia cells in response to drugs
that inhibit the mammalian target of rapamycin (mTOR) pathway, induce apoptosis,
or prevent translational activity directly at the ribosome. Our method was able to
discern a particular growth signature for each drug investigated and to discover a
new phenotype in cells following mTOR inhibition. Furthermore, our data demon-
strates that the instantaneous growth rate changes following a drug treatment could
potentially predict the long-term inhibitory effect on cellular biogenesis and mass
accumulation.
Thesis Supervisor: Scott R. Manalis
Title: Professor of Biological and Mechanical Engineering
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Chapter 1
Introduction
1.1 Background
Traditional in vitro techniques that are used for investigating the effects of a chemother-
apy on cancer cells reveal the extent to which a cell population proliferates, performs
biosynthesis, or progresses through the cell-cycle. For example, flow cytometric anal-
yses following drug exposure report the percentage of cells that have undergone DNA
synthesis based on the measured BrdU incorporation (Fillmore and Kuperwasser,
2008; Olsson et al., 2006; Ouyang et al., 2002). Clonogenic assays monitor cell pro-
liferation by looking for the formation of drug resistant cell colonies 1-3 weeks after
the initial treatment (Fiebig et al., 2004; Franken et al., 2006). MTT and MTS as-
says estimate the concentration of viable cells following drug exposure based on the
aggregate color changes that occur when formazan dye is chemically reduced within
functional mitochondria (Carmichael et al., 1988; Romijn et al., 1988; Wang et al.,
2010). While widely used, techniques such as these provide only the steady state
responses of cells to chemotherapy. Furthermore, they report the bulk averages of a
population which can mask both the heterogeneous and the dynamical processes of
the single cell (Longo and Hasty, 2006; Zare and Kim, 2010).
Without the use of cell synchrony, assays that bulk average across various phases
of the cell-cycle cannot discern the time-varying response of an individual cell (Spiller
et al., 2010). However, synchronization of a mammalian cell line is not only difficult to
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achieve but may also perturb the cells and produce undesirable artifacts in behavior
(Davis et al., 2001). Nevertheless, even if perfect synchrony were possible, cell-to-
cell heterogeneity would still exist in an isogenic population. For example, the time
required after the initial drug treatment for each individual cell to reach a particular
event, such as apoptosis, are not uniform even amongst sister cells (Spencer et al.,
2009). In addition, cell-fate may not be the same, i.e., the degree to which molecular
events are inhibited or affected within a population may differ.
Individual cells contribute to the behaviors of a larger population, and highly
resolved single-cell responses may contain information about underlying biological
processes that cannot be observed in the bulk (Irish et al., 2006; Reya et al., 2001).
One approach that can comprehensively elucidate a cell’s response to drug treatment
is the direct observation of single-cell growth throughout both its native and its
perturbed state (Figure 1). Such measurements not only allow cell-to-cell variability
to be distinguished but also enable the contrast of a particular cell’s normal behavior
with that following drug treatment. In the last decade, several powerful techniques
have been introduced to monitor single-cell growth, but as yet there are no methods
that can fully appreciate the long-term effects of drug therapy on mammalian cells.
Microscopy has long been the technique of choice when it comes to observing
single-cell growth and proliferation. For example, time lapse bright-field microscopy
on a microfluidic device has enabled the observation of bacteria before and after treat-
ment with antibiotics (Balaban et al., 2004). However, this technique is limited by its
ability to precisely determine the size of a three-dimensional object. The growth rate
was not derived from the increase in size of a single bacterium but from the aggregate
one-dimensional elongation of all daughter cells arising from a single identified per-
sister cell. More recently, microscopy involving the readout of a fluorescent reporter
protein has been used to correlate cell mass to particular events in the yeast cell cycle
and to ascertain the exponential growth kinetics of a single yeast cell (Talia et al.,
2007). Although in general cell mass is comprised mainly of intracellular proteins,
growth dynamics cannot be entirely represented by protein synthesis. Furthermore,
this method has not been extended to mammalian cells nor has it been utilized to
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observe the effects of perturbation. Quantitative phase microscopy (Davies et al.,
1990; Mir et al., 2011; Popescu et al., 2008) can directly measure cell mass, but
this technique lacks the necessary precision to determine individual mammalian cell
growth. Advanced interferometric microscopy has a much better resolution (∼1% of a
mammalian cell’s mass in standard deviation), but a recent implementation to study
the therapeutic response of mammalian cells (Reed et al., 2011) did not obtain the
growth rate before drug treatment. A fundamental limitation of the method, which
ultimately precluded instantaneous and frequent sampling of growth rate after drug
treatment, was the 1-hour time interval required for cells to settle in a 6-well plate
upon introduction of new fluid. In addition, cells were monitored for only five hours
following the initial exposure, not long enough to observe potential intergenerational
effects.
An ideal method for tracking growth dynamics in response to extrinsic perturba-
tions would allow for direct and precise mass measurements, support the long-term
survival and proliferation of the cell under investigation, and enable drug or stimulus
delivery to the cell’s environment during observation. In order to create an approach
that satisfies each of these criteria, we engineered cell trapping and fluid exchange
techniques to work in concert with the suspended microchannel resonator (SMR), a
sensor that can detect buoyant mass with an unprecedented mass resolution of ∼1
femtogram in a 1 Hz bandwidth (Burg et al., 2007).
1.2 System Concept
1.2.1 Mass Sensor
A recent development in mass sensing technology, the suspended microchannel res-
onator (SMR), has reported a resolution six orders of magnitude better than that of
a state-of-the art quartz crystal balance (Burg and Manalis, 2003; Burg et al., 2007).
The sensing ability of a micromechanical resonator can be modeled on the same prin-
ciple that governs a mass on a spring system. Any change in cantilever mass results
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in a shift in resonant frequency, f, given by:
f =
1
2pi
√
k
m∗ + α∆m
(1.1)
The parameters k, m∗, ∆m, and α denote spring constant, effective mass, change in
mass, and geometric correction factor. Thus, high sensitivity, or ∆f
∆m
, is contingent on
the cantilever having a low effective mass and a pure ring tone. The quality factor,
or Q, is an indication of how well the resonator performs as a mass sensor. The Q
factor is inversely related to the amount of damping and is defined as the total energy
stored over the energy dissipated per cycle. While unparalleled in detecting minus-
cule changes of mass in a vacuum, resonators have limited resolution for measuring
biological targets which inevitably require a fluid environment. Viscous drag forces
from the surrounding impose a substantial amount of damping, thereby increasing the
sensor’s effective mass and severely reducing the Q factor. The SMR uniquely circum-
vents this problem by bringing the solution environment into a microfluidic channel
embedded within a silicon cantilever while it continues to oscillate in a vacuum (Burg
et al., 2006).
A cell transit through the embedded channel (Figure 1-2A) is detected as a down-
ward peak in resonant frequency (Figure 1-2B). From the SMR’s perspective, a cell
would result in the greatest amount of increase in the sensor’s effective mass when it
approaches the apex, the most sensitive region of the cantilever. This change in mass,
reflected as the maximum change in resonant frequency, represents the buoyant mass
of the cell. Defined as the mass of a cell in fluid, the buoyant mass is directly related
to the amount of biomass in a cell and can be described mathematically as:
mB = Vcell · (ρcell − ρfluid) (1.2)
where V and ρ are cell volume and density respectively. Since a majority of a cell’s
biomass is more dense than water, the buoyant mass, as a metric, is analogous to dry
mass (Godin et al., 2010).
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1.2.2 Basic SMR Operation
The oscillation of an SMR can be maintained in resonant frequency at all times
through a positive feedback loop consisted of an optical lever system (Figure 1-3A)
and electronics (Figure 1-3B). As in an atomic force microscope (AFM), a focused
laser beam is reflected off of the vibrating cantilever (Alexander et al., 1989; Manalis
et al., 1996) as it fluctuates in and out of the focal plane. The laser is then collected at
a split photodiode where a cyclical focusing and defocusing of light is translated by a
photodetector circuit to an analog sinusoid with a period equivalent to the reciprocal
of the cantilever’s resonant frequency. An oscillator circuit then optimizes the drive
signal by amplifying and by phase shifting the sinusoid 90 degrees (Appendix A).
The SMR can be actuated either electrostatically via electrodes fabricated within
the vacuum packaging or mechanically via a vibrating piezoelectric crystal in contact
with the device.
For frequency determination, the photodetector signal is read by a frequency
counter (HP 5313A) and by a data acquisition (DAQ) system (NI-6259). The baseline
resonant frequency of the SMR typically ranges from 200 - 400 MHz. Although the
frequency counter can estimate that value with high precision (error at 10 ppb), it
is limited by a readout rate of 2 data point per second. Events such as cell transit
which take place on the order of 100 milliseconds cannot be resolved. The second
method of frequency determination, the DAQ system, has a sampling clock rate at
80 MHz, but the readout rate is limited by the period of the input signal. In other
words, frequency readout occurs only after an entire period of the sinusoid has been
measured, or sampled, by the clock. Thus, if the photodetector signal oscillated too
quickly or too slowly, certain changes in buoyant mass that result in resonant fre-
quency shifts cannot be precisely determined. In the extreme case, the former would
have a readout dominated by noise as not enough samples were taken per period,
and the latter would not have enough readouts per second to resolve short time-scale
events (Figure 1-4A). Because the resonant frequency shift of interest ranges from
1-100 Hz, a 200 - 400 MHz signal need not be analyzed in its entirety. Instead, the
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last 1 KHz of the resonant frequency can be sampled by the DAQ system resulting
in peak-to-peak noise < 1Hz and an overall readout rate of 1ms. To achieve this,
a multiplier circuit convolves the photodetector signal in the frequency domain with
a digitally synthesized sinusoid and then filters for the lower frequency component.
The result is a sinusoid with a frequency equal to the difference between that of the
two convolved signals (Figure 1-4B).
In addition to the embedded channels of the cantilever, the microfluidics of the
SMR device consists of two larger conduits which carry fluids from a reservoir up-
stream to a reservoir downstream of the mass sensor (Figure 1-5A). These bypass
channels enable sample delivery to and from the hollow cantilever. The fluid flow
through the device is controlled pneumatically by two computer activated pressure
regulators (Proportion Air QPV1-TFEE-030-CXL) that are multiplexed by solenoid
valves (SMC S070C-6DG-32). The four fluidic ports to the bypass channels (two
upstream and two downstream) are connected via 1
32
” FEP tubings (Upchurch Sci-
entific 1686) to tightly sealed air pressurized containers (VWR 80076-582). Under
normal operations, sample is delivered from a single upstream source through the
bypass channels to two separate waste vials. The fluid flow rates through the device
and across the SMR can be leveraged by adjusting the pressure differential between
the source and the waste vials. Each pressurized vial can toggle between one of three
pressurized states: P1, P2, and atmosphere. The adjustable P1 and P2 (gauge pres-
sure range 0-30 psi) correspond to the values set by the computer activated pressure
regulators. During a priming or rinsing event, the upstream source is pressurized at
P1 and both the wastes vials are vented to atmosphere (Figure 1-5A). In some situ-
ations, pinch flow to force the fluid from one bypass to the other through the SMR
may be required. The source and one waste vial is pressurized at P1 while the second
waste vial is pressurized at P2, where P1 > P2 (Figure 1-5B). Lastly, gravity serves
as a means to finely control the fluid flow through the SMR. The effective pressure
within a particular vial can be adjusted by increasing or decreasing the height of the
vial or the level of the fluid. Leakage flow across the SMR can either be amplified
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or eliminated simply by accounting for gravitational effects without modifying the
pressure settings on the pressure regulators.
1.2.3 Cell Traps and Drug Delivery
The primary goal of this thesis is to develop and to utilize an integrative high-precision
microfluidic instrument for monitoring single mammalian cell stimulation and drug
response. We consider a variety of cell traps that can be implemented within the
SMR to capture a cell against flow for instantaneous drug delivery and for continuous
mass measurements. Methods such as acoustic wave (Evander et al., 2007), dielec-
trophoresis (Gray et al., 2004; Issadore et al., 2010), and optical trap (Johann, 2006;
Wang et al., 2003) are particularly enticing because no physical contact with a cell is
necessary. These techniques form a stable trap around a cell by transferring momen-
tum via mechanical or electromagnetic waves. However, the complexity of the SMR
device, including vacuum packaging and multiple glass and silicon layers, makes it dif-
ficult to implement acoustic wave and dielectrophoresis without a complete and costly
redesign. Whereas acoustic wave require a source in close proximity to the channel,
dielectrophoresis require the fabrication of electrodes in a specific arrangement within
the device.
Optical trap, on the other hand, is not limited by either of these constraints.
It involves the focusing of a high-powered laser beam down to a diffraction-limited
spot forming a sharp gradient in photon density. A dielectric object, such as a cell,
near the center of the trap experiences a gradient force from the photons it refracts
and a scattering force from the photons it reflects (Ashkin et al., 1986; Svoboda and
Block, 1994). When the two force components are balanced, the result is a stable
three-dimensional trap that sits slightly beyond the focal point of the laser (Ashkin,
2000; Block, 1992; Lang and Block, 2003; Rohrbach and Stelzer, 2002). Chapter 2
describes the design and construction of a prototype optical trap SMR instrument. It
also presents hydrodynamic calculations and considerations relevant to not only the
optical trap but also to subsequent cell trap implementations (Appendix B).
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Mechanical traps such as constrictions (Carlo et al., 2006; Wheeler et al., 2003)
or posts (Valero et al., 2005; Werdich et al., 2004) surrounding a dock restrict the
movement of a captured cell but continue to allow fluid carrying nutrients and other
analytes to pass. Although physical contact with a cell is required, mechanical traps
guarantee sufficient force to immobilize a cell against fluid moving at low to moder-
ate flow rates (0.1-1nL s−1). While adding physical structures to the SMR requires
fabrication of new devices, the modification is minor and is limited to the initial re-
active ion etching (RIE) step at which the embedded channels of the cantilever are
formed. The operation of the device, including functionality and noise floor, is pre-
served. Chapter 3 details two particular implementations of mechanical trap SMRs:
the first conducted density measurements of yeast cells while the second observed the
short-term effects of mammalian cells following exposure to sodium azide. Appendix
C discusses centrifugal force from the SMR’s oscillation, the technological discovery
which enables a cell of interest to be trapped on demand within the confines of the
mechanical structures.
Godin, Delgado et al. (2010) introduced the concept of dynamic trapping to
measure the time course mass accumulation of bacteria, yeast, and mammalian cells
within the SMR. While the mass sensor detects cell transits through the cantilever,
a control software simultaneously keeps track of the transits and iteratively readjusts
the settings on the pressure regulators to prevent the cell from leaving the SMR. The
resulting motion of the cell within the channel is analogous to a ping pong ball moving
back and forth between two paddles. By combining dynamic trapping with periodic
cell storage and a newly developed single-cell manipulation technique to perform drug
delivery, we created the microfluidic mass-based analysis of single-cell stimulation, or
MMASS, to discover the long-term effects of drugs on cells. Chapter 4 presents the
culmination of this work: the utilization of MMASS to study single cancer cells before
and after treatment with protein synthesis inhibitors that act on different timescales.
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1.4 Figures
Figure 1-1: In order to fully understand a mammalian cell’s response to a therapeutic intervention,
one must first monitor the cell in growth media to obtain its normal growth characteristics. At some
arbitrary time, the same cell is treated with a particular drug and monitored again thereafter. Even
amongst a seemingly homogeneous population, cell-to-cell variabilities may yield widely different
results at the individual cell. Having the ability to distinguish which cells are not growing well prior
to the perturbation is essential. The central theme of this thesis is the development and application
of an instrument to achieve such measurements.
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Figure 1-2: The mass sensing region of the suspended microchannel resonator (SMR) consists of a
vacuum-packaged cantilever with an embedded microfluidic channel. (A) A series of cartoons (i-iii)
illustrates a cell moving from the first bypass conduit of the device through the cantilever and into
the second bypass conduit. (B) An example readout demonstrating what the frequency of the mass
sensor would look like while the cell is at various positions of the device (i-iii).
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Figure 1-3: The oscillation of the SMR is amplified via a positive feedback loop consisting of optics
and electronics. (A) An optical lever system much like that of the atomic force microscope (AFM)
is used to detect the oscillation of the SMR. A 635 nm (red) laser is focused down to a diffraction-
limited spot on the cantilever. A periodic focusing and defocusing of the light is projected onto a
photodetector and is converted to a voltage signal. Each device is equipped with two fully functioning
SMRs. The optics shown here take advantage of s and p polarization to enable dual readout. (B)
The voltage signal, a sinusoid with respect to time, is amplified and phase shifted at the drive
circuit. The SMR can be actuated electrostatically via electrodes or mechanically via a piezoelectric
crystal. In parallel, the photodetector signal is mixed down to a lower frequency and sent to a data
acquisition card.
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Figure 1-4: (A) The DAQ, sampling at fclock, can acquire more samples per period if the frequency
of the input signal is lowered. More samples result in lower noise per readout. However, if the
frequency of the signal is too low, the interval between each readout would be too long to resolve
fast events such as cell transits. (B) Indicated here is an idealized scheme by which the photodetector
signal is mixed down. The result is a sinusoid with a frequency equal to the difference between that
of the photodetector signal and that of the synthetic sinusoid. We have found that a mixed-down
frequency centered about 1kHz is at an optimal trade-off between noise and readout speed.
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Figure 1-5: Fluid is driven by pressure through the SMR device. A combination of valves and pres-
sure regulators allow each vial (both downstream and upstream) to multiplex between atmosphere,
P, and P-∆P. The latter two are given in gauge pressures. (A) This configuration is commonly used
for priming the device. The system flushes fluid from a single upstream vial through all tubings
and bypass channels. (B) In this mode, the system forces all the fluid in one bypass to pinch flow
through the SMR into the second bypass. The downstream waste vial on the second bypass could
either be at P-∆P or at atmosphere depending on the desired magnitude of flow rate.
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Chapter 2
Cell capture against flow:
implementing optical tweezers
2.1 Motivation
By combining the mass-sensing capabilities of the SMR with a single laser beam
optical trap (Figure 2-1A,B), also known as optical tweezers, we can capitalize on
decades of research manifesting the deft for capturing, probing, and manipulating
micron-sized objects with radiation pressure (Block, 1992, 1995; Lang and Block,
2003; Wright et al., 1989). Utilizing forces on the order of 1-100 pN (Ashkin et al.,
1986; Huang et al., 2009), Ashkin et al. (1987) studied the proliferation of bacteria
and yeast cells while dragging individual cells up to a velocity of 500 µm s−1 and
100 µm s−1 respectively. This demonstrated that cell viability can be maintained
even after hours of laser exposure. Optical tweezers have also been used to probe
viruses (Ashkin and Dziedzic, 1987), understand cell movement (Block et al., 1989;
Takahashi et al., 2003), and perform force spectroscopy on single molecules (Lang
et al., 2002, 2004; Neuman and Nagy, 2008).
In order to harness the power of the optical force within the SMR, we must first
examine the physical constraints of the device. Since a cell is immobilized against
hydrodynamic drag, understanding the flow rates and the fluidic profile within the
cantilever provides us with an approximate magnitude of force required to keep the
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cell captured. Understanding the optical characteristics of silicon allows us to not only
maximize the transmission of light through the cantilever but also to minimize heating
from laser absorption. The considerations provided here, however, have implications
beyond just the optical trap implementation. They are central in the development of
an optical imaging system as well as in the design of cell traps for later generations
of the instrument.
2.2 Design considerations
2.2.1 Fluid dynamics
In order to solve for the velocity profile in the rectangular channels of the SMR (Figure
2-2A), we employed the Navier-Stokes equation in Cartesian coordinates. The flow
of an incompressible fluid through the hollow cantilever is steady and fully developed
since the fluid velocity does not vary in the axial direction, dVz
dz
= 0 , or in time, d
~V
dt
= 0.
It is laminar as expected of a fluid in the low Reynold’s number regime. Furthermore,
without any rotational or swirling component in the velocity, a fully developed flow
can only be unidirectional (Vx = 0 and Vy = 0). Under these conditions, the inertial
effects on flow are neglected in the microfluidic channel (Whitesides, 2006). Since
gravitational effects are assumed negligible for this calculation, the Navier-Stokes
equation reduces to the Poisson’s equation:
1
µ
dP
dz
=
[
d2Vz
dx2
+
d2Vz
dy2
]
where P is the pressure drop across the channel, µ is the viscosity of the fluid, and
Vz is the fluid velocity in the axial direction. Using harmonic analysis (see appendix
A), we found that the solution of the Poisson’s equation is in the form
Vz(x, y) =
∑
k=odd
∑
l=odd
ak,lcos
(
kpi
Lx
x
)
cos
(
lpi
Ly
y
)
(2.1)
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where ak,l are the Fourier series coefficients, Lx is the width of the channel, and Ly
is the height of the channel. The coefficients of the sine series equal zero as a no-slip
boundary condition is imposed on the walls. At a low flow rate equivalent to half of
the entire SMR volume per second, the parabolic flow reaches a maximum velocity of
482 µm s−1 and 717 µm s−1 near the center of an 8x8 µm and a 15x20 µm channel
respectively. At these velocities, the Reynolds number (Re) is ∼0.01, confirming that
fluid movement is viscous-dominated inside the SMR. The velocity profiles for both
types of channels are shown in Figure 2-2B,C.
We estimated the drag force on a cell (with a radius r) immobilized in the midst
of the channel by substituting an average fluid velocity into Stoke’s law:
Favg = 6piµr
[
1
A
∫ ∫
A
Vz(x, y) dxdy
]
(2.2)
Table 2-1 lists the average optical forces required to immobilize objects traveling
through the SMR with various flow velocities, presented as transit durations and
pressure drops across the channel. We found that for a trap to be effective in cap-
turing a mammalian cell, it must be able to generate approximately 30 pN within
the embedded channels of the cantilever. Optical tweezers can typically produce a
force of ∼1 pN per mW (Farinato and Dubin, 1999). Based on this prediction, we
estimated that ∼30 mW of laser power at the specimen plane is required.
2.2.2 Particle oscillation
In viscous dominated flow, changes in fluid velocity profile in response to an applied
pressure or a surface movement will occur instantaneously (Deen, 1998). For example,
if the pressure differential across a conduit is suddenly removed, the flow will not
slow to a stop but will rather cease immediately. An object that is vanishingly small
compared to the channel dimensions and has a negligible mass typically follows the
streamlines exactly even when the velocity fields change. However, as the object
becomes larger, its mass inevitably increases precluding inertial effects from being
ignored. In response to a step change in velocity field, a drag force will be imposed
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on the object until its velocity matches that of the streamlines once again.
From the perspective of an object within the SMR, the oscillation of the cantilever
consistently changes the fluid velocity profile in the y-direction (Figure 2-1A). For an
object sizable enough such that inertial effects are nontrivial, its velocity and the
fluid velocity are at a constant mismatch. We investigated the resulting differences
in displacement between the object and the fluid so that we might understand how
this oscillation affects the immobilization of a cell.
The velocity of the cantilever and the fluid within is represented as the time
derivative of the cantilever oscillation
v(t) =
dy(t)
dt
= −Aωsin(ωt)
where A is the amplitude of oscillation, ω is the frequency of oscillation, and y(t) is
the cantilever displacement. Applying Stoke’s law, we found that the drag force on
an object is depicted by the first order differential equation
F =
[
ρ
4
3
pir3
]
dvp
dt
= 6piµr
[− Aωsin(ωt)− vp] (2.3)
where vp, ρ
4
3
pir3, and r are the object’s velocity, buoyant mass (mb), and radius
respectively. The parameter ρ is the density difference between the object and the
surrounding fluid medium. In appendix A, we determined that the solution to (2.3)
is
vp = − ΦAω
2
ω2 + Φ2
exp(−Φt) + ΦAω
2
ω2 + Φ2
cos(ωt)− Φ
2Aω
ω2 + Φ2
sin(ωt) (2.4)
where Φ = 6µr
mb
, a constant that relates the fluid viscosity to the object’s buoyant
mass. To find the object’s displacement (yp), we integrated vp with respect to time
and evaluated the boundary condition of yp = A at t = 0.
yp =
A
ω2 + Φ2
[
ω2exp(−Φt) + Φωsin(ωt) + Φ2cos(ωt)
]
(2.5)
Table 2-2 lists the steady state amplitude of oscillation for four spherical objects
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each with a density similar to that of a cell (ρcell = 1.1 g cm
−3) but with dramatically
different radii, r  {100 nm, 1 µm, 5 µm 10 µm}. We assumed that the cantilever
oscillates with a maximum amplitude of ∼100 nm at a frequency of 200kHz and that
the fluid within has a viscosity of 0.89 centipoise. The results show that objects with
a radius less than 1 µm experience negligible resistance to displacement and follow
the oscillation of the cantilever almost exactly. However, for an object larger than
1 µm, inertial effects from its buoyant mass become substantial, and its movements
become more sluggish with increasing size.
One interesting observation to note is that the oscillation of the cantilever hydro-
dynamically focuses the object at the equilibrium point, or the position at which the
cantilever’s displacement, y(t), is 0. As time increases, the exponential term in (2.5)
becomes negligible and the object’s oscillation consists purely of two sinusoids with
no position offset. For example, if a 10 µm object were initially displaced by 100nm
in the y-direction, it would travel that length to center its oscillation about the equi-
librium point despite only having a steady state oscillation amplitude of ∼31.5 nm.
A caveat to take into consideration, however, is that for an object with a diameter
on the order of the channel’s height, its resistance to movement is, in fact, mitigated
by the higher resistance of the fluid layers closer to the walls. Although both the
5 µm and the 10 µm objects will in reality experience a larger displacement than
estimated because of this effect, we can conclude from this analysis that inertia will
confine micron-sized objects such as cells to oscillation amplitudes well within a few
tens of nanometers. Vascillations of this magnitude are unlikely to eject the object
from a stable trap formed by optical tweezers.
2.2.3 Heat transport
Two coherent light sources, the frequency readout laser and the optical tweezers, are
each focused down to a diffraction-limited spot either on the surface of or within
the cantilever. Absorption of light can potentially heat the fluid inside the embedded
channel to a temperature incapable of sustaining cell survival. To estimate the magni-
tude of heating, we must first consider the optical properties of the cantilever. Silicon,
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the primary material of the SMR, has a low transmittance and a high absorbance for
light throughout the visible and part of the IR spectrum. The percentage of trans-
mittance, reflectance, and absorbance of light passing through the cantilever (Figure
2-3A) is determined based on the data provided by Aspens (1988); Hull (1999).
To estimate heat transfer, we employed a lumped-element circuit model (Figure
2-3B) where the fluid and silicon layers are modeled as resistances in parallel. Heating
is assumed to take place at one end (the cantilever apex), and the other end (the base)
is assumed to be at an infinite heat sink due to a large device to cantilever size ratio.
Writing the equation for the circuit model, we obtained
∆T = P (Rsi||Rwater) = P
[
RsiRwater
Rsi +Rwater
]
(2.6)
where P is the laser power that is absorbed by the material. The thermal resistance,
like electrical resistance, is defined as
R =
1
κ
L
A
(2.7)
where κ is the conductivity, L is the length of the resistor, and A is the cross-sectional
area. We substitute equation (2.7) into (2.6) and get
∆T = P
[
L
Asiκsi + Awaterκwater
]
(2.8)
The κwater=0.6 W K
−1 m−1 and κsi=150 W K−1 m−1. Since both the cross sectional
area and the heat conductivity of silicon is larger than that of water, the contribution
of the fluid layer can effectively be neglected (Asiκsi >> Awaterκwater).
To get an upper bound on temperature increase, we computed the heat transfer
for the 8x8 µm channel which has a higher thermal resistance than its counterpart
15x20 µm channel. For the 635 nm readout laser, the power is attenuated down
to ∼50 µW before reaching the SMR. According to Figure 2-3A, the absorbance of
silicon at 635 nm is ∼65%. Evaluating (2.8), we found that the temperature increase
due to the readout laser is less than 1 K. We used the same technique to estimate
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the heat transfer due to the optical tweezers. Since the cantilever transmits slightly
more than 50% of light in the near infrared spectrum, we determined that 100 mW
of laser power entering the SMR can provide more than the estimated required force
of 30 pN at the specimen plane. Figure 2-3C summarizes the temperature increase
for a range of near infrared wavelengths. We found that at 1064 nm, the cantilever
heating is at most 13.75 K. Since the clamp holding the SMR device is thermally
controlled, we can adjust for a temperature increase on this order simply by cooling.
In our lumped-element circuit model, we assumed that fluid convection does not
affect the temperature of the cantilever. To assess the validity of this assumption, we
calculated the time constant for heat conduction
τd = d
2 σC
κwater
(2.9)
where d, σ, and C are thickness, density, and heat capacity of the fluid layer. For a
thickness of 8 µm, τd is equal to 446 µs. At this time scale, the fluid traverses less
than 2% of the entire cantilever length even when moving at a high flow rate of twenty
times the SMR volume per second, or equivalent to an average velocity of 9.2x103 µm
s−1. From this result, we can conclude that the effects of convection is minimal and
that for low to moderately high flow rates, the fluid is in thermal equilibrium with
the channel walls.
2.3 Optical trap prototype
2.3.1 Microscope objective and laser
To achieve strong optical gradient force requires not only sufficient laser power but also
a tightly focused spot at the trap position. This necessitates a microscope objective
with a high numerical aperture (NA) which typically means that the working distance
is short. The SMR, however, is encased on the bottom side by 0.6-1mm of Pyrex and
vacuum combined. Therefore, the objective must have a long working distance such
that the laser may penetrate multiple layers before focusing on the specimen plane.
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The use of oil-immersion to achieve a higher NA is precluded by the vacuum which
limits the maximum effective NA of any objective at unity. Light entering this region
from beyond the critical angle will experience total internal reflection. Additionally,
the thick Pyrex creates aberrations at the focus by introducing phase shifts in the
axial direction of the trap (Rohrbach and Stelzer, 2002). Because of its large working
distance (0.95-1.3 mm) and its high NA (0.85), the CFI L Plan EPI CRB 100x Nikon
objective is chosen. It also has a variable cover-slip thickness correction (0.6-1.3 mm)
which ameliorates the aberrations from the Pyrex to achieve a better focus.
To provide sufficient laser power while avoiding excessive cantilever heating, we
selected a continuous wave IR Laser at 1064nm (Ventus IR from Laser Quantum)
which has a maximum output of 3W. At this wavelength, the cantilever absorbs less
than 3% and transmits more than 50%. Accounting for the main components of the
optical tweezers (mirrors, lenses, beam splitters, objective, Pyrex, silicon), we found
that ∼80% of the initial laser power is dissipated even before the light reaches the
fluid layer. If we assume a fiber coupling efficiency of 50%, then the maximum amount
of power we can attain at the specimen plane is ∼300mW, or 10 times the estimated
amount required to immobilize a mammalian cell.
2.3.2 SMR reimplementation
Both the optical tweezers and the readout laser must have access to the cantilever.
To facilitate the process of alignment, we decoupled the two optics. Because the
optical trap setup also contain an imaging system, it is comparatively bulkier than
the frequency detection optics. We redesigned the frequency detection so that the
entire contraption (laser, optics, and photodetector electronics) can be suspended
from above allowing it access to the cantilever from the top side. Figure 2-4A shows
the ray tracing diagram for the optical lever readout. In order to minimize weight, we
simplified the optics down to a beam splitter and a customized objective (meniscus
lens and achromatic doublet) with an effective focal length (EFL) of 50 mm. The
beam splitter allows 50% of the incident collimated laser to proceed and focus onto the
cantilever through the objective. It also allows 50% of the collimated rays returning
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from the cantilever to be reflected onto the photodetector. Rather than using mirrors
to steer the beam, we mounted the 635 nm laser directly onto a tilting stage. By
rotating the position of the laser, we can pinpoint the position of the diffraction-
limited spot to the apex of the SMR. The photodetector circuit is assembled on a
cage plate attached to a kinematic mount so that it may be clamped onto the damped
post which suspends the rest of the frequency detection optics.
2.3.3 Optical tweezers and imaging system implementation
The ray tracing diagram for the optical tweezers is provided in Figure 2-4A. The
1064 nm laser is fiber coupled and attached to the optics via an FC connector. Two
mirrors in series serve as the course adjust for aligning the laser through the center
(z-axis) of the microscope objective. A pair of lenses (focal lengths: -40 mm and 100
mm) is positioned in a Galilean telescope arrangement to achieve a beam expansion
ratio of 1.67:1. The expansion allows the laser to overfill the back aperture of the
microscope objective enabling the trap to take advantage of the maximum NA. While
the distance between the beam expansion lenses can be finely adjusted to control the
focal point of the laser in the axial direction (z-axis), the center point of the second
lens with respect to the first lens can also be adjusted to control the lateral position
(x-y direction) of the trap in the specimen plane. After the expansion, the laser is
reflected by a broadband IR beam splitter (45% reflection, 55% transmission) and is
directed by a 45◦ mirror into the back aperture of the objective.
In order to visualize the inside of the cantilever, we implemented an imaging sys-
tem that utilizes epi-illumination (Figure 2-4A). For illumination, we used a monochro-
matic source at 940 nm, a wavelength with sufficient transmission through silicon
while distinct enough such that the trapping laser does not interfere with the image.
Light from a 1W diode is collimated and then injected into the system via a broad-
band IR beam splitter. The collimated light is focused onto the back aperture of the
objective through a 200 mm tube lens and is again collimated at the specimen plane
to avoid forming a light bulb image within the cantilever. Reflected light carrying the
image from within the SMR is collimated through the objective and is then focused
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by the 200 mm tube lens onto the CCD camera. A 1 µm short-pass filter allows
>80% transmission of the image (at 940 nm) to the camera and attenuates ∼99% of
the reflected light from the 1064 nm laser.
The optical portion of the instrument, excluding the lasers and the photodetec-
tor mount, is shown in Figure 2-4B. For stability and ease of alignment, all lenses
and mirrors are mounted on a cage system. The SMR device is enclosed within a
temperature-controlled clamp consisting of a top copper and a bottom aluminum.
The clamp is mounted on a 3-axis stage enabling the quick alignment of a new or
a different SMR device without having to readjust the configurations of the optical
tweezers and the frequency readout optics.
2.4 Trap assessment and discussions
2.4.1 Trap stiffness
Much like a mass on a spring, any object held by optical tweezers will experience
a Hookean restoring force for small displacements away from the trap center. Thus
stiffness, in units of a spring constant, is a conventional metric for measuring the
strength of optical tweezers. To make this assessment, we performed the Stokes drag
calibration in which the restoring force of the trap was equated to the hydrodynamic
drag applied by a fluid velocity v on a trapped object with a radius r (Appleyard
et al., 2007).
F = kx = 6piµrv (2.10)
To determine the stiffness coefficient k, we measured x, the displacement of an
object away from the trap center, for various fluid velocities. Since the relationship
between x and v is linear, we fitted a first order polynomial (x=Mv+b) through
the data points and extracted the slope M . The stiffness was then calculated from
k = 6piµr
M
. In place of the SMR device, we used a glass flow cell mounted on an
automated motorized stage. Following the capture of a 3.2 µm polystyrene bead by
the optical tweezer, the stage executed the following program: wait, apply a positive
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velocity of a known magnitude, wait, and apply a negative velocity of the same
magnitude. The duration of each step lasted only for a few seconds. When the stage
applied a velocity on the flow cell, the fluid within would move against the object and
displace it from the center of the trap. The entire sequence was recorded into file by
a video camera on the imaging system. Each frame of the video was analyzed by a
particle tracking algorithm that calculated the bead’s position based on a weighted
centroid of the pixels. A least squares fit of all the positions measured was used to
determine the displacement of the bead from the center of the optical trap (Figure
2-5A).
The results of the displacement versus fluid velocity calibration is shown in Figure
2-5B. The stiffness of our trap (with 50 mW of laser power at the specimen plane)
was 0.0362 pNnm−1. Appleyard et al. (2007) reported a similar stiffness value but
for 30 mW of laser power. We attributed this discrepancy to the difference in the
microscope objectives of the two instruments. Whereas Appleyard et al. (2007) used
a 1.25NA oil immersion objective, we required one with a long working distance ∼1
mm which limited the NA to 0.85. Having less NA meant that there was a higher
proportion of low angle incident rays (scattering force) than there was of the wide
angle incident rays (gradient force) in our trap. Although both the scattering and
the gradient forces were necessary for a dielectric object to be captured by optical
tweezers, an increased amount of scattering would result in a weaker trap.
To obtain the maximum attainable optical force on a captured 3.2 µm object, the
motorized stage was programmed to sweep across a number of velocity step increases.
We found that a step increase of 210 µm s−1 was the fastest fluid velocity for which
the bead would still remain trapped. Evaluating this in (2.10), we concluded that
the maximum attainable optical force was 5.6 pN which was similar to the calculated
value from table 2-1: a 3.2 µm object transiting the entire length of the SMR in 2
seconds would require ∼6.1 pN to immobilize.
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2.4.2 Conclusions
Using laser powers up to 100 mW at the specimen plane, or three times the estimated
amount required, we tried to trap various micron sized objects traveling through the
SMR. However, we were unable to form a stable trap inside the cantilever regardless
of the object’s dimension or shape. Despite the optical tweezer’s ability to generate
forces in a glass flow cell that rivaled the hydrodynamic drag within the SMR, the
trap was severely weakened by interference when positioned inside the cantilever.
The top silicon wall, only a few microns away from the focus, reflected and scattered
the laser resulting in the destabilization of the optical tweezers. In our attempts to
capture an object within the SMR, we leveraged flow rates approaching the lower
limits achievable by the pressure regulators. Bulk flow through the bypass channels
were already too slow for any appreciable fluid exchange to occur. Thus, even if we
could optically trap an object by further reducing the transit velocity, doing so would
not be practical. Transient pressure instabilities from flow rate increase during drug
delivery would suffice to remove a trapped object from within the cantilever. In the
end, the SMR device which imposed geometric restrictions on the selection of a high
NA microscope objective also limited the laser’s ability to form a tightly focused spot,
one that was free of distortion from interference. Both of these factors synergistically
resulted in a weak or unstable trap.
Cell viability considerations regarding prolonged laser exposure on a cell has di-
rected us to explore alternatives. Liu et al. (1996) reported that a 1064 nm laser
at 88 mW will exert substantial damage on mammalian cells if the exposure is for
more than 5 minutes. In order to monitor long-term cellular growth dynamics and
response to drugs, the SMR must be able to weigh a single cell on the times scale
of hours. The idea of mechanical traps came about originally as a method to assist
optical tweezers. A cell is initially captured optically against flow and guided into
a dock. Thereafter, the laser can be turned off, and the dock will hold the cell in
place during the drug delivery process. In this scheme, the exchange can occur at
high flow rates because the cell is unlikely to leave its confinement. As the possibility
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of optically immobilizing a cell against flow within the SMR began to wane, mass
sensors with mechanical traps became its own method for capturing and monitoring
cells.
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2.6 Figures
Figure 2-1: Illustration of an optical tweezer positioned within the SMR. (A) Cell trapped by the
optical tweezer at the apex of the cantilever. (B) Frequency readout as a cell is trapped.
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Figure 2-2: (A) A flow cell representation of the cantilever’s embedded channel. We report the
fluid velocity profile within the SMR for (B) an 8x8 µm channel and (C) a 15x20 µm channel at a
flow rate equal to one-half of the channel’s total volume per second.
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Figure 2-3: (A) Optical properties of silicon ∼25 µm in thickness. (B) Lumped-element circuit
model of cantilever heating due to focused laser sources. Computation is based on the steady-state
model. (C) ∆T at the cantilever apex for an infrared laser at various wavelengths penetrating the
surface of the SMR at 100mW.
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Figure 2-4: (A) Ray tracing diagram for: 1) frequency readout (red); 2) optical tweezer (black);
3) imaging system (yellow). (B) The optical system.
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Figure 2-5: (A) A particle tracking algorithm was used to determine the displacement of a trapped
bead as a result of applied velocity. Red: frame-by-frame bead position was calculated by weighted
centroids. Blue: least squares fit to determine the actual displacement. (B) The displacement
of a 3.2 µm object away from the optical trap center for various applied velocities. The stiffness
coefficient was determined from the slope of the first order polynomial fit.
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2.7 Tables
Table 2-1: The approximate forces required to trap a cell traveling through the SMR
at various transit times. The pressure drop across an 8x8 µm and a 15x20 µm channel
for the listed transit times are also reported. The value 0.003* psi approaches the
lower limits of what can be achieved across the SMR by the pressure regulator.
.
Transit ∆P8x8µm D=1 µm D=3.2 µm D=5 µm ∆P15x20µm D=10 µm
t=50ms 0.24 psi 77 pN 246 pN 394 pN 0.12 psi 1.06 nN
t=100ms 0.12 psi 38 pN 123 pN 192 pN 0.06 psi 578 pN
t=2s 0.006 psi 1.92 pN 6.14 pN 9.60 pN 0.003* psi 28.9 pN
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Table 2-2: The maximum oscillation amplitude of micron-sized objects as a result
of SMR vibration. The inertial effects for objects with diameters on the order of
channel height are mitigated by the higher resistances of fluid layers close to the wall.
In actuality, the amplitudes of oscillation for the 5 and 10 µm objects should be
slightly higher than the values reported here.
Object Oscillation Amplitude (nm)
SMR 100
D=100nm 100
D=1µm 100
D=5µm 78.6∗
D=10µm 31.5∗
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Chapter 3
Mass sensors with mechanical
traps for weighing single cells in
different fluids
3.1 Abstract
We present two methods by which single cells can be mechanically trapped and contin-
uously monitored within the suspended microchannel resonator (SMR) mass sensor.
Since the fluid surrounding the trapped cell can be quickly and completely replaced
on demand, our methods are well suited for measuring changes in cell size and growth
in response to drugs or other chemical stimuli. We validate our methods by measur-
ing the density of single polystyrene beads and Saccharomyces cerevisiae yeast cells
with a precision of approximately 10−3 gcm−3 and by monitoring the growth of single
mouse lymphoblast cells before and after drug treatment.
3.2 Introduction
The suspended microchannel resonator (SMR) enables single-cell measurements of
buoyant mass with femtogram-level resolution (Burg et al., 2007; Godin et al., 2010).
The SMR consists of an embedded microfluidic channel inside a cantilever that res-
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onates in an on-chip vacuum. Cells or particles with a different density than the
surrounding fluid cause a small change in the cantilevers resonant frequency as they
flow through the cantilever, and their buoyant mass can be determined from the mag-
nitude of the frequency change. The buoyant mass, or mass of a particle in fluid, is
defined as
mbuoyant = V (ρp − ρf ) (3.1)
where V is the particle volume, and ρp and ρf are the particle and fluid densities,
respectively.
Early SMR implementations could provide the buoyant masses of cells in a pop-
ulation but could weigh each cell only once and were unable to monitor single cells
over time (Bryan et al., 2010). Later systems added fluidic controls to implement
dynamic trapping, during which an individual cell is repeatedly passed back and
forth through the SMR. When maintained over extended time periods, this dynamic
trap can measure the growth of individual cells in real time (Godin et al., 2010).
But delivering chemical stimuli to a dynamically trapped cell is challenging because
viscous-dominated flow inside the microchannel ensures that the cell moves along
with the surrounding fluid.
Recently, Grover et al. (2011) showed that by loading the SMR device with two
different fluids, single cells can be dynamically trapped within the two fluids, weighed
in the first fluid and then weighed in the second fluid. This technique is well suited
for measuring the density of single cells by weighing them in two fluids of different
densities. However, their technique is unsuitable for measuring the response of a
cell to chemical stimuli because the duration of exposure of the cell to the second
fluid is limited to only a few seconds, and the growth rate of a single cell cannot
be measured both pre- and post-treatment with a drug. Finally, the buoyant mass
measured by this method is subject to uncertainty caused by variations in the cells
flow path through the cantilever. A novel strategy for overcoming these limitations
is to physically trap each cell within the SMR. The buoyant mass of the cell could
then be monitored continuously while the fluid surrounding the cell is changed at
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will. Several designs for cell traps were considered: methods such as standing acoustic
waves (Evander et al., 2007), dielectrophoresis (Gray et al., 2004; Issadore et al., 2010)
and optical trapping (Johann, 2006; Wang et al., 2003) have their appeal in that no
cell contact is necessary and that the action of capturing and releasing a cell can be
readily controlled. However, while it is possible to generate forces on the order of
tens to hundreds of piconewtons by applying acoustic or electromagnetic waves in an
ordinary microfluidic channel, the multilayered geometry and complex design of the
SMR device make it difficult to implement these techniques. Mechanical structures
involving cell-sized docks preceding a constriction (Valero et al., 2005; Werdich et al.,
2004) and U-shaped trapping compartments (Carlo and Lee, 2006; Carlo et al., 2006;
Kim et al., 2008; Wheeler et al., 2003) proved to be more robust cell capturers for
our application.
Mechanical trapping structures integrated with the SMR can effectively load and
unload a single cell while its buoyant mass and the density of the surrounding fluid
are continuously monitored. We evaluated two types of mechanical trap: the first,
referred to as three-channel SMRs (Figure 4-1A,B), proved to be most suitable for
single-cell density measurements, while the second type, referred to as columned
SMRs (Figure 4-1C), was used to measure cell growth before and after exposure to a
drug.
3.3 Three-channel SMRs
3.3.1 Method
Three-channel SMRs were fabricated as described previously (Burg et al., 2007) with
a capture dock at the apex of the cantilever (Figure 4-1A,B) and a third fluidic
channel used to control flow into and out of the dock. At the T-junction where the
dock meets the third channel (channel 3), a narrow constriction allows fluid to pass,
but not cells of the appropriate size. Two versions of the three-channel SMR with
different dimensions were fabricated: one with a 3x8 µm channel cross-section and a
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200 nm wide horizontal slit; and another with an 8x8 µm channel cross-section device
and a 2 µm wide vertical gap. A computer-controlled fluidic system orchestrates a
sequence of pressure changes that traps a cell, measures its buoyant mass, quickly
replaces the fluid around the cell, measures its buoyant mass a second time in the
new fluid, and ejects the cell.
To prime the device, fluid 1 flows from bypass channel B1 to the cantilever. Fluid
1 carries the cells to be measured (Figure 4-2, blue). Relative pressure settings ensure
that the majority of fluid 1 travels from B1 to the second bypass B2 via the SMR
to minimize the likelihood of cells being captured in the dock. After the device is
primed, the fluid velocity through the SMR is reduced, and pressure on the bypass
B3 is lowered so that a significant amount of the fluid now flows through the third
channel. Thus, a transiting cell will be directed into the pocket and captured (Figure
4-4 inset). Cell capture is detected as a stepwise change in the resonant frequency
due to the change in mass inside the cantilever (if the cell sinks, mass increases and
frequency decreases; if the cell floats, mass decreases and frequency increases). Cell
immobilization eliminates position uncertainty, a source of error, which exists when
measuring samples in a flow through mode.
After a cell is trapped, the computer reverses the flow to flush the SMR with
fluid 2 (Figure 4-2, red) from bypass channel B2. Fluid 1 is completely rinsed out of
the cantilever, leaving the cell immersed in fluid 2. Prior to removing the cell from
the trap, bypass B3 is filled with fluid 2, and a constant flow is maintained. This
clears out remnants of fluid 1 that have previously exited through the third channel
and is crucial for preventing the two fluids from mixing during the ejection step.
The control system then gradually pressurizes the third channel until the cell leaves
the dock. After the cell is ejected, there is another step in the resonant frequency
corresponding to the buoyant mass of the cell in fluid 2. The entire sequence of
events takes 3-5 s and can be observed in Supplementary Movie 1. The duration of
serial measurements depends on cell concentration. Smaller concentrations of cells
will increase the delay between measurements, but high concentrations will lead to
multiple cells being trapped.
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With two buoyant mass measurements and two measurements of the fluid density,
the cells density can be determined. The device is calibrated with fluids of known
density, allowing the density of fluids 1 and 2 to be accurately determined. The cell
density is, therefore, determined as:
ρcell =
mbuoyant2 · ρfluid1 −mbuoyant1 · ρfluid2
mbuoyant2 −mbuoyant1 (3.2)
Measurement error in the cells density is affected by the choice of densities of fluids
1 and 2. If the reference fluid densities are close, the buoyant mass values in both
fluids will also be close, and the measurement error will play a more significant role in
(3.2). This error was minimized by choosing reference fluids as far apart in density as
was convenient. Furthermore, we took care to bracket the samples density between
the fluid densities (fluid 1 is less dense than the cell, and fluid 2 is more dense than
the cell). In order to calculate volume and mass, the sensitivity of the SMR, relating
buoyant mass to cantilever resonant frequency change, was determined with NIST
size standard beads as previously reported (Godin et al., 2010). Note that since the
buoyant mass calibration factor affects all the buoyant mass terms proportionally in
(3.2), calibration is not actually required for measuring cell density.
3.3.2 Material
Buffers Yeast was grown and measured in yeast extract plus peptone medium sup-
plemented with 2% glucose and 1 mg mL−1 adenine (YEPD) and bacteria in Luria-
Bertani (LB) broth (Sigma-Aldrich L2542). For the secondary fluid for the den-
sity measurements we used Milli-Q ultrapure water, deuterium oxide (Sigma-Aldrich
151882) and a 1:9 dilution of 10x PBS (Omnipur 6505) in high-density Percoll (Sigma-
Aldrich P4937, modified as reported by Grover et al. (2011)).
Cells Saccharomyces cerevisiae cells (strain A2587) were grown in YEPD at 30 ◦C
with agitation and measured about 2.5 hours after the culture had been started, prior
to beginning of exponential growth phase. Escherichia coli (ATCC 25922) were grown
in LB overnight at 37 ◦C then diluted 1:100 an hour before the measurement.
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Polystyrene Beads The beads used in the measurements and calibrations were the
size standards from Bangs Labs NT17N (1.9 µm) and Thermo Scientific 4205A (5
µm).
3.3.3 Results
We first applied this technique to polystyrene beads, which were measured in water
(ρ = 0.9983 g cm−3) and deuterium oxide (ρ = 1.1046 g cm−3). All experiments were
performed at 23.3 ◦C. The measurements, shown in Table 4-1 and Figure 4-3 for 1.9
µm and 5 µm beads, were carried out in the 3x8 µm and 8x8 µm devices respectively.
The results, ρ1.9 = 1.0497 ± 0.0010 g cm−3 and ρ5 = 1.0491 ± 0.0008 g cm−3 (mean
± standard deviation), matched the reported density of polystyrene (∼1.05 g cm−3).
In addition, we determined the population statistics of the calculated diameters by
assuming the volume of a sphere in (3.1). Both samples showed lower standard
deviations and coefficients of variation than the ones reported by the manufacturers
(Table 4-1).
The method was also used to measure the density of S. cerevisiae cells with an
8x8 µm SMR. The results obtained by consecutive measurements of the cells in their
medium (ρ = 1.0182 g cm−3) and PBS:Percoll (ρ = 1.1667 g cm−3) are shown in
Figure 4-4. An average cell density ρ = 1.1042 ± 0.0057 g cm−3, CV = 0.59%, n
= 244 (totaling 2 runs) was determined. This value is in accordance with single-cell
yeast density measurements obtained through other methods (Table 2). The two
experimental runs were measured from two samples taken from the same culture, one
hour apart. The measured densities were ρ = 1.1049 ± 0.0068 g cm−3, CV = 0.62%
for the earlier one (n=132) and ρ = 1.1033 ± 0.0061 g cm−3, CV = 0.56% for the
later sample (n=112). The results for calculated mass are m = 95.08 ± 46.30 pg, CV
= 48.7% and volume V = 78.1 ± 35.3 µm3, CV = 45.2% and V = 95.9 ± 47.5 µm3,
CV = 49.6%, respectively. The data of the two separate measurements are shown
in Supplementary Figure 3-1. Volume was also measured with a Coulter Counter
(Beckman Coulter, Multisizer 4), V = 78.5 ± 49.2 µm3, CV = 62.6% and V = 91.45
± 58.5 µm3, CV = 64.0%, respectively (n = 20,000 cells).
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3.3.4 Discussion
The results demonstrate that our method can accurately determine the density, mass,
and volume of single cells to the extent that osmotic shock can be avoided or min-
imized and that the density of the cell being measured can be bracketed by the
appropriate solution densities. More than one cell can be trapped at the same time if
a cluster of cells enter simultaneously or if the flow reversal time is not short enough
to prevent an additional cell from being captured. For density measurements, the
capture of multiple cells will result in a measured average, which will mask the vari-
ability amongst those cells. However, these events can be detected optically or by
size signatures and can be rejected by data analysis.
We further attempted to achieve the same measurement on bacterial cells (E. coli)
with the 3x8 µm SMR. However, although single bacterium can be trapped within
the pocket, ejection proved to be difficult without large pressure differentials due to
cell adhesion to the walls. Further developments such as bacteria-resistant surfaces
(Cheng et al., 2009) are still required to successfully measure the density of single
bacteria.
3.4 Columned SMRs
3.4.1 Method
In order to measure the drug response of single cells, we used our existing process
(Burg et al., 2007) to fabricate SMRs of 15x20 µm cross-sectional area with 3 µm
diameter trapping columns that are spaced evenly by 3 µm in a U-shape located
either at the side or at the center of the cantilever apex (Figure 4-1C). Two larger
bypass channels (100 µm in diameter) deliver fluid to and from the SMR. Under
normal device operation, a sample containing cells suspended in a carrier medium
(Figure 4-5, blue) is first loaded via pressure driven flow. A single cell entering the
SMR that happens to be caught within the columns will result in a step-wise change
in resonant frequency corresponding to an increase or decrease in total sensor mass.
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Most cells flowing through the SMR follow the path of least resistance and are
diverted away from the columns. In order to optimize the likelihood of trapping a
cell within the columns, two additional technical components are employed. First,
the pressure drop across the SMR is precisely adjusted by a combination of both
ambient and hydrostatic control to reduce or eliminate fluid flow; and second, the
SMR is driven at higher amplitudes to appreciate a significant centrifugal force on
the cell (Lee et al., 2010b). The SMR is typically actuated only by electrostatic
forces from an adjacent electrode. In order to generate sufficient vibration amplitude
for guiding the cell into the columns, piezoelectric actuation tuned in phase with
the electrostatic drive is superimposed. Piezoelectric actuation has been shown to
produce a few microns of amplitude in SMR oscillation (Lee et al., 2010a). This in
turn exerts a nanonewton-scale centrifugal force on a 10 µm polystyrene bead, which
provides enough acceleration to move a bead at rest near the cantilever apex into the
trapping compartment in less than a second. The average centrifugal force is given
by the following equation
Fc =
mb
2L
[(
ΦAω2
ω2 + Φ2
)2
+
(
Φ2Aω
ω2 + Φ2
)2]
(3.3)
where Φ = 6µr
mb
, µ is viscosity of the fluid medium, mb is the buoyant mass of an
object with a radius r, A is the amplitude of oscillation, ω is the angular frequency
of oscillation, and L is the length of the SMR. Although a similar approach can be
used for trapping cells, an overall smaller centrifugal force is experienced by a cell
suspended in growth medium. In order to compensate for this, stop flow (or zero
pressure differential) across the cantilever must be imposed when a transiting cell
arrives at the vicinity of the columns allowing sufficient time to accelerate the cell
into the mechanical trap. Appendix C discusses the centrifugal force in greater depth.
Once the cell is trapped, a pressure differential across the cantilever is resumed. This
is achieved by applying pressure-driven flow to the upstream of both bypass channels.
The flow rate on one side is greater than the other in order to prevent the cell from
escaping the trap as a new fluid carrying a drug or stimulus enters the SMR (Figure
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4-5, red). When the fluidic exchange is completed, the SMR resonant frequency
stabilizes. Reversing the flow effectively removes a cell from the trap, resulting in
another step-wise shift in resonant frequency.
A drug response experiment begins by employing the dynamic trapping method
(Godin et al., 2010) to measure the instantaneous growth rate of the cell. The cell is
then mechanically trapped within the columns as described previously, and a new fluid
containing the drug is delivered as depicted in Figure 4-5. Following drug delivery,
the cell is ejected from the columns and dynamic flow trapping is utilized once again
to monitor the buoyant mass of the cell. When compared to statically holding a cell
within the SMR, monitoring buoyant mass by dynamically trapping the cell has the
important advantage that the baseline signal is measured after every passage in order
to correct for drift.
3.4.2 Material
Buffers Cells were grown and measured in Lebovitzs L15 medium (Invitrogen 21083027)
supplemented with 10% FBS (Invitrogen no. 16000-044), 0.4% glucose (Sigma-
Aldrich G8769) and 1% penicillin/streptomycin mix (Cellgro MT-30-002-CI) at 37
◦C. Sodium azide (Sigma Ultra S8032-100G) was added for drug treatment experi-
ments. Deuterium oxide (Sigma-Aldrich 151882) was used as the second fluid for the
polystyrene bead measurement.
Cells L1210 mouse lymphoblasts were grown in medium (L-15+FBS+glucose+penstrep)
inside tissue culture flasks at 37 ◦C and at 5% ambient carbon dioxide. Cell culture
was maintained in log phase by periodically diluting and re-suspending cells in fresh
medium every two days. Total cell count in culture was kept between 50 x 103 mL−1
and 200 x 103 mL−1. To fix cells, 5 mL of a saturated culture (cell count at 1 x
106 mL−1) was spun down (150 rcf for 5 minutes), washed with 1x PBS, and then
re-suspended in 0.5 mL 100 mM phosphate buffer + 0.5 100 mM phosphate buffer so-
lution with 7.4% Formaldehyde and 4% Glutaraldehyde. The sample was then left at
room temperature overnight and later washed and re-suspended in 1x PBS. The fixed
cells were kept at 37 ◦C overnight to ensure that any possible molecular exchange
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between the cells and the medium have reached equilibrium.
Polystyrene Beads The beads used in the measurements and calibrations were from
Bangs Labs NT27N (10 µm).
3.4.3 Results
As with the three-channel SMRs, the feasibility of fluidic exchange for the columned
devices was first assessed using 10 µm diameter polystyrene beads. Figure 4-5 reports
on this proof of concept experiment. The bead is sinking in water when it is captured
in the columns. Following complete fluid replacement, it is then floating in deuterium
oxide. In contrast to the three-channel SMRs, any new fluid entering the columned
SMRs must first replace the contents of both bypass channels. Thus, the entire process
of fluidic exchange, which typically requires 3 to 5 minutes, takes substantially longer
than can be achieved by three-channel SMR.
We measured the growth rate of L1210 mouse lymphoblast cells before and after
fluidic exchange in three conditions: 1) a single growing cell before and after a control
exchange from medium to like medium; 2) a single growing cell before and after
exchange from medium to medium + 1% sodium azide; 3) a single fixed cell before and
after a control exchange from medium to like medium. Cells that were exchanged from
medium to like medium grew at comparable rates before and after fluidic exchange
(Figure 4-6A), indicating that shear stress from the fluidic exchange does not alter the
short-term growth properties. In contrast, cells that were exchanged from medium to
medium + 1% sodium azide exhibited a negative growth rate immediately following
exchange (Figure 4-6B). Sodium azide causes ATP synthesis to shut down, which
results in depolarization of the cell due to inhibition of active transporters on the
plasma membrane in ion exchange (Davies et al., 1990; Riemersma, 1968). An increase
in osmotic pressure inside the cell stimulates an increase in uptake of water and
thereby decreases the density of the cell. As a result, the buoyant mass decreases. The
negative growth rate exhibited following treatment with sodium azide is a biophysical
manifestation of the cells inability to maintain a concentration gradient across the
plasma membrane. Results from additional measurements are summarized in Figure
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4-7.
3.4.4 Discussion
We demonstrated that the columned SMRs can effectively monitor the buoyant mass
of a cell before and after drug treatment. However, the columned SMRs have several
drawbacks: i) long-term growth studies (in excess of 60 minutes) have not yet been
possible to achieve because shear stress from the continuous flow trapping and the
fluid exchange ultimately affects cell viability, ii) small pressure fluctuations during
the fluidic exchange process can cause the cell to squeeze through the column gaps
and escape the trap, and iii) the entire procedure requires approximately an hour
to measure the drug response from one cell. The last two drawbacks, when taken
together, resulted in an effective throughput of about one cell per day. Nevertheless,
the method in its current state can be used to gain biophysical insight into how drugs
alter the ability of a cell to uptake nutrients immediately following exposure to a
drug.
3.5 Conclusion
Our work augments current SMR capabilities with single-cell manipulation techniques
based on mechanical trapping structures. This capability enables measurements that
are not possible using flow-through mass sensing. The ability to measure the buoyant
mass of an individual cell in two fluids allows its density as well as its response to
a drug to be measured. We measured the density, mass, and volume of individual
yeast cells in their culture medium and in PBS:Percoll solution. We also measured
the dynamics of buoyant mass accumulation and loss in mouse lymphoblast cells
before and after complete buffer replacement with and without the presence of a drug
or stimulus. We developed two approaches for making these measurements. In the
first, three-channel SMRs capture single cells and rapidly exchange the surrounding
buffer for a new fluid. Consecutive buoyant mass measurements in different fluids
are rapidly acquired without the need for microfluidic mixing. This approach is not
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optimal for monitoring growth behavior of the cells prior to and after drug delivery
as the presence of a third channel introduces fluidic pressure variations that prevent
stable dynamic flow trapping. To address this limitation, we developed columned
SMRs that enable a complete fluid exchange throughout the system by temporarily
capturing a cell. Dynamic flow trapping can be resumed without hindrance following
fluid exchange, thereby allowing for effective growth monitoring before and after drug
delivery.
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3.8 Figures
Figure 3-1: Top perspective of SMRs with mechanical traps. Three-channel SMRs with different
third-channel dock geometries: (A) 3x8 µm device with a 200 nm horizontal slit and (B) 8x8 µm
device with a vertical 2 µm wide opening. (C) Columned SMR.
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Figure 3-2: SMR resonant frequency response is plotted versus time as the density of a 5 µm
polystyrene bead is measured. (A) SMR is filled with water. (B) A bead is trapped. The short
spike at the end of the step is due to the bead rounding the corner of the wall, before entering the
pocket; (C) Water is replaced by D2O. (D) The particle is ejected.
69
Figure 3-3: Density and mass of polystyrene size standard beads measured in two different three-
channel devices. Mean densities: (a) 1.9 µm particles ρ = 1.0497 ± 0.0010 g cm−3, CV = 0.09%, n
= 231 (b) 5.003 µm particles ρ = 1.0491 ± 0.0008 g cm−3, CV = 0.08%, n = 247.
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Figure 3-4: Density and mass of S. cerevisiae cells. Mean density ρ = 1.1042 ± 0.0066 g cm−3,
CV = 0.59%, n = 244. Inset plot Density and mass of 5 µm polystyrene beads measured in the
same conditions as the cells. Scales are the same as the main plot. The biological variability as
determined by the spread of cell measurements is less than the instrument variability as predicted
by the measurement and dispersion of bead samples. Inset picture Immobilized cell (circled). Scale
bar: 10 µm.
71
Figure 3-5: Columned SMR device operation. (A) Empty channel; (B) 10 µm polystyrene bead
(green, ρ =1.05 g cm−3) is trapped in H2O (blue, ρ =1.00 g cm−3); (C) Fluid is exchanged to D2O
(red, ρ =1.10 g cm−3); (D) Bead is ejected from trap.
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Figure 3-6: The buoyant mass versus time of individual L1210 mouse lymphoblast cells. (a) Con-
trol: monitored in medium (red) and exchanged into medium (blue). (b) Drug delivery: monitored
in medium (red) and exchanged in medium with 1% sodium azide (blue).
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Figure 3-7: The growth rates of all L1210 mouse lymphoblast cells monitored before and after
fluidic exchange. The fixed cell measurements determined the noise floor of the technique to be
-0.1296 ± 0.1109 pg hr−1 before the exchange and -0.0809 ± 0.1697 pg hr−1 after the exchange.
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3.9 Tables
Table 3-1: Density and population statistics of the diameter of polystyrene beads.
Diameter was calculated from (3.1) assuming the volume of a sphere. Mean values (*)
of diameter are the same by definition as they were used as buoyant mass calibration,
therefore the values are merely indicative.
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Table 3-2: Reported measurements of yeast density. (Aiba et al., 1964; Baldwin and
Kubitschek, 1984; Haddad and Lindegren, 1953; Reuss et al., 1979)
76
3.10 Supplementary Data
Supplementary Movie 1 Two consecutive measurements of yeast cells, each in
medium and PBS:Percoll.
Supplementary Movie 2 The demonstration of inertial trapping in the columned
SMR using a polystyrene bead.
Supplementary Figure 3-1: Density and mass of S. cerevisiae cells. The plot is the same as
Figure 4, but distinguishes the two different samples. The measured densities were ρ = 1.1049 ±
0.0068 g cm−3, CV = 0.62% for the sample measured 2 hour after the culture was started (red,
n=132) and ρ = 1.1033 ± 0.0061 g cm−3, CV = 0.56% for the sample measured 3 hour after the
culture was started (blue, n=112). Inset plot Density and mass of 5 µm polystyrene beads measured
in the same conditions as the cells. Scales are the same as the main plot.
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Chapter 4
Measuring the dynamics of
single-cell growth in response to
drug therapy
4.1 Abstract
Measurements that describe the average response of a cell population to a pertur-
bation can obscure the behaviors of individual cells, which may be heterogeneous or
may contain information not described by bulk averaging. Here, we developed a mi-
crofluidic system that enables sensitive, long-term single-cell growth measurements in
response to dynamically changing environmental conditions. Using this system, we
demonstrated that cells can exhibit significantly different growth responses to three
distinct drugs which act, at least in part, by inhibiting protein synthesis. In addition,
we showed that the instantaneous responses of single cells to drug intervention may
predict long-term responses of both single cells and bulk populations. The tools and
findings described here may have implications for mapping chemical, genetic, or en-
vironmental perturbations to classes of cellular responses and for rapidly predicting
drug responses in patient-derived samples.
79
4.2 Introduction
Cell growth is an important phenotype for assessing drug response. The most com-
plete characterization of the effect of a chemical perturbation on cell growth would be
to dynamically monitor the change in size of individual cells before and after expo-
sure to a drug. This would reveal not only the variation in growth dynamics between
cells within the population but also how a particular cell alters its own behavior in
response to a therapy.
Aldridge et al. (2012) recently achieved single-cell growth measurements by using
microscopy to monitor the length of mycobacterial cells within microfluidic channels.
They found that asymmetric growth and division results in subpopulations of cells
that vary in their susceptibility to clinically relevant classes of antibiotics. Previously,
Balaban et al. (2004) used a similar method to observe persister E. coli cells. They
discovered that these cells, which were not antibiotic resistant but persisted after
ampicillin treatment, grew at a lower rate than untreated cells even prior to drug
exposure. A lower than normal growth rate is an inherent characteristic of persister
cells and not the result of antibiotic treatment. Although analogous studies with
mammalian cells could potentially provide valuable, finely-resolved insights into the
individual responses of cancer cells to drugs, an appropriate method still does not
exist.
Three essential criteria are required for establishing a growth monitoring system
for mammalian cells: i) the size of irregularly shaped cells must be monitored with
high precision over extended periods of time; ii) cells must proliferate in the system
as they do in standard cultures; and iii) the drug must be uniformly delivered to the
cells within a defined time period without perturbing cell growth from excess shear
stress. Each of these criteria has been separately demonstrated. For example, Lecault
et al. (2011) developed a microfluidic platform containing thousands of nanoliter-scale
chambers suitable for live-cell imaging studies of clonal cultures of nonadherent cells
with precise control of the conditions over periods approaching 100 hours. However,
the conventional microscopy used in their study, while appropriate for monitoring
80
cell proliferation, was not suitable for measuring cell size with meaningful precision.
In contrast, Reed et al. (2011) used interferometry, an advanced form of optical
microscopy (DAVIES and WILKINS, 1952), to measure the dry mass of cells with
a precision of nearly 1%. However, cells were not tracked before drug delivery and
were only monitored for five hours after the initial treatment. Recently, we used
a suspended microchannel resonator (SMR) with mechanical traps to observe the
dynamic changes in the buoyant mass of a cell before and after sodium azide exposure
(Weng et al., 2011). However, studies in excess of an hour could not be achieved
since shear stress from continuous dynamic trapping for growth monitoring (Godin
et al., 2010) would eventually degrade cell viability. Furthermore, the throughput was
extremely low because cells trapped in mechanical structures were frequently lost due
to pressure fluctuations during drug delivery .
Here we have created a method called the Microfluidic Mass-based Analysis of
Single-cell Stimulation (MMASS) which satisfies each of the essential criteria de-
scribed above. MMASS uses the SMR to measure the buoyant mass of single mam-
malian cells with a precision near 0.05%, and its measurements are not influenced
by cell morphology (Burg et al., 2007). It employs an advanced dynamic trapping
system, which uses periodic cell storage, to enable continuous monitoring of a cell and
its progeny for over a hundred hours and tens of generations without compromising
viability (Son et al., 2012). More importantly, this method incorporates a single-
cell manipulation technique we have developed specifically to provide an on-demand
evolution of a cell’s surrounding from one fluid environment to another within a five-
minute window. As the cell successively moves between two larger bypass channels
through the SMR, the contents of each are incrementally refreshed. In this fashion,
the same cell can be transferred from normal growth media to growth media contain-
ing an added drug without introducing additional stress which may alter or affect
growth. Using MMASS, we measured the growth of single cancer cells before and
after drug therapy with high resolution, revealing unexpected cellular behaviors that
provide new insights which may be useful for rapidly predicting drug activities in
cells, including limited cell populations.
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4.3 Results
MMASS is loaded sequentially upstream of the SMR with growth media (Figure 4-1,
blue) followed by growth media carrying a drug (Figure 4-1, red). Cells are loaded
downstream by forming a fluidic loop from one bypass channel to the other through
the embedded channels of the cantilever. As a cell flows through the SMR, its buoyant
mass is reflected as a peak in sensor frequency. To keep the cell dynamically trapped,
the system reverses flow every time a cell transit through the SMR is sensed. During
this iterative process, the cell is brought out deep into the bypass channels and a
substantial amount of fluid is displaced (Figure 4-1A-F) until all of the existing growth
media upstream has been exchanged with new growth media containing a drug. Due
to a density tag placed within the carrier media, the sensor baseline frequency shifts
when the drug enters the SMR and stabilizes when the drug has been delivered at
full concentration.
Because shear stress resulting from fast or frequent transit through the SMR into
nearby bypass channels can perturb growth, we first established that the dynamic
trapping and drug delivery processes do not alter the long-term growth trajectory,
the viability, and the interdivisionary period of the cells. We accomplished this by
measuring the growth of single mouse lymphocytic leukemia cells (L1210) before
and after exchanging the growth media vial with another vial of identical growth
media. Figure 4-2A shows the growth, or mass accumulation, of a cell (black line)
and that of its subsequent generations (colored lines ). The first cell was dynamically
trapped and monitored until mitosis, after which one of the two daughter cells was
expelled and the other was kept for additional monitoring. This process occurred
at the end of every cell-cycle, resulting in the multiple single-cell trajectories shown.
The media exchange took place during the growth of the first cell and is denoted
by the demarcation between the red and the blue backdrop. To determine if the
media exchange altered the growth trajectory, it is helpful to observe how the growth
rate of each cell (defined as the rate at which it accumulates mass) changes as it
progresses through the cell cycle. Figure 4-2B plots the growth rate (time-derivative
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of trajectories shown in Figure 4-2A) as a function of the cell mass at the time the
derivative was calculated. Every trajectory in Figure 4-2B, which is color-coded to
correspond to its generation shown in Figure 4-2A, spans from the mass at which
the cell was born to that at which it divided. As the cells increased in mass, their
growth rates also increased. This observation agrees well with a previous study by
Tzur et al. (2009). Furthermore, the individual cell’s growth rate versus mass was
overlaid on a gray shading which represents the estimated range of expected values
derived from control cells (N=12) grown in pure media, which were consistent with
those of a more extensive growth study (N=100) by Son et al. (2012). All cells grew
near or within the expected growth rate and mass ranges. The first cell’s growth
rate remained unaffected by the fluidic exchange (denoted by the asterisk) and even
slightly exceeded the range of expected growth rates just prior to mitosis. In addition,
the interdivisionary period of a single-cell was found to be approximately 10 hours,
which is in agreement with bulk measurements from a healthy culture (Rauscher and
Cadman, 1983).
We used MMASS to monitor the growth of L1210 cells before and after treat-
ment with 250 nM Torin1, a selective molecule inhibitor of the mTOR kinase, which
regulates cell growth, cell cycle progression, and protein synthesis (Figure 4-2C and
Supplementary Figure 4-3A-F) (Guertin and Sabatini, 2007, 2009; Liu et al., 2010;
Sarbassov et al., 2005). Single-cell responses were quantitatively heterogeneous but
shared principle qualitative features. We found that single-cell growth appeared
largely unaffected immediately (2-4 hours) following drug treatment, but at later
times (5-10 hours), growth of the treated cell (Figure 4-2C, green) began to slow
appreciably relative to controls grown without Torin1. Smaller cell masses were ac-
companied by progressively increasing interdivisionary periods (Figure 4-2C, blue and
Supplementary Figure 4-3) and decreasing cell sizes at division. Typically, a complete
cessation of mass accumulation was observed 1-3 divisions after the initial treatment
of a cell. In some cases, this was followed by a significant loss of mass. Figure 4-2D
shows that the growth rate versus mass of cells (black and red) prior to drug treatment
fell within the expected range of control cells. Although the first treated cell (green)
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continued to grow at approximately the same rate shortly after drug treatment, it
was neither able to reach the mass nor attain the growth rate of its predecessors
at mitosis. The subsequent generation (blue) exhibited lower birth size, total mass
accumulation, and growth rate, leading eventually to zero or negative growth.
We next investigated the growth response of L1210 cells following treatment with
two additional inhibitors of growth and protein synthesis, staurosporine (STS) and
cycloheximide (CHX). STS is a multi-targeted kinase inhibitor that is capable of
inducing apoptosis through both caspase-dependent and -independent mechanisms
(Belmokhtar et al., 2001). Figure 4-2E and Supplementary Figure 4-4 show that cells
treated with 3 µM STS exhibited slower than expected mass accumulation beginning
2 hours post-treatment, followed by a dramatic loss of mass at approximately 5 hours.
Figure 4-2F shows that following STS-treatment, a cell continued to increase in mass
at a steady rate before falling short of the expected range of growth rates. In contrast,
treatment with cycloheximide (CHX) (5 µg mL−1), an inhibitor of eukaryotic protein
biosynthesis that interferes with the translocation step in translation (Baliga et al.,
1969), resulted in an almost immediate impairment of cell growth, with complete
growth inhibition within 2-3 hours of treatment, followed again by a significant loss
of mass (Figure 4-2G and Supplementary Figure 4-5). Figure 4-2H indicates that
upon treatment with CHX, the cell exhibits a dramatic change in growth rate which
immediately fell below the expected range of an unperturbed cell.
We further investigated whether or not short-term single cell drug response data
may provide insights into longer term cellular behaviors. As shown in Figure 4-3A,
there is a correlation between the amount of time required for a cell to stop growing
and the instantaneous effects of the drug on the same cell as represented by the growth
rate ratio (GRR), which is determined by the ratio of the growth rates calculated
within 30-minute windows before and after delivery of the drug. To assess the effects
of each drug on the growth of a population of cells, we measured leucine incorporation,
a proxy for total mass accumulation (Figure 4-3B). As expected, we found that CHX,
which results in the lowest GRR, reduces population protein synthesis by more than
90% within two hours of exposure. At the other end of the spectrum, Torin1, which
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results in the highest GRR, suppresses protein synthesis by 47% nearly a day after
the initial treatment. STS, which results in an intermediate GRR, reduces protein
synthesis by more than 90% some time between 5 and 20 hours of exposure. Finally,
we hypothesized that impairment of single-cell mass accumulation may also affect
proliferation because progression through the biosynthetic phases of the cell cycle
would be expected to occur more slowly. To determine if there is a relationship
between growth and proliferation, we performed a 72-hour time-lapsed cell count
on a bulk population following treatment with the same drugs and found that cells
treated with drugs that decrease growth rate also proliferated at significantly slower
rates than did control (DMSO-treated) cells (Figure 4-3C).
4.4 Discussion and Conclusion
To our knowledge, MMASS is the first system that allows for the high-precision mea-
surement of long-term growth dynamics in single mammalian cells during exposure
to dynamically changing environmental conditions. Control experiments involving
single-cell growth in media followed by an exchange into the same media have shown
that the method of drug delivery does not affect the growth dynamics of an unper-
turbed cell. A comparison of interdivisionary period between single-cell and bulk
measurements further supports the observation that cells are viable and divide regu-
larly from one cell cycle to the next in this system.
Using MMASS, we resolved the growth dynamics of individual cells in response to
pharmacological perturbations. We found that three drugs, each of which impairs cell
growth at least in part by inhibiting protein synthesis, cause distinct cellular growth
trajectories on differing timescales, suggesting differing modes of action. Additional
mechanistic insights can also be ascertained from these measurements. For example,
by measuring individual cell growth before and after the addition of CHX, a drug
which potently inhibits protein translation, it is possible to place an upper limit
on the amount of time required for drug transport through the cell membrane and
subsequent ribosome inhibition to impact cellular-level growth processes (2-3 hours).
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Second, a cell treated with STS, a multi-targeted kinase inhibitor known to induce
apoptosis (Belmokhtar et al., 2001), maintains a significant period of continued growth
(3-8 hours) before it begins to show signs of mass loss, a likely indicator of apoptosis
(Bortner and Cidlowski, 2002). Our findings contrast those of a prior report which
demonstrated an increase in cell density due to volume loss shortly after exposure to
STS, implying that the cell responds to this drug within minutes (Grover et al., 2011).
Interestingly, this discrepancy suggests that an STS-treated cell is capable of growth,
i.e. nutrient uptake, protein synthesis, and mass accumulation, despite undergoing
an initial rapid loss of volume.
We also demonstrated that following treatment with Torin1, a cell does not change
its growth appreciably until 5-10 hours post-drug treatment, when its growth rate be-
gins to slow substantially as compared to cells grown in pure media. Decreased growth
rates, smaller cell sizes at division, and progressively increasing interdivisionary pe-
riods follow, all of which are consistent with the known role of the mTOR pathway
in growth and cell-cycle regulation. The eventual cessation of mass accumulation ob-
served in single cells parallels the cytostasis observed in bulk populations treated with
Torin1 (Thoreen et al., 2009). These data provide the first direct evidence that the
smaller cell sizes which commonly result from mTOR inhibition (Guertin and Saba-
tini, 2009) are the result of successively smaller cell sizes at division, which result in
successively smaller daughter cells, rather than the direct shrinking of a cell upon
drug addition. This phenomenon may reflect the depletion of an mTOR-controlled,
limiting cellular factor required for proper cell growth. According to this hypothesis,
the inhibition of mTOR results in the diminished abundance of this factor, which is
diluted upon successive rounds of cell division until a critical threshold is reached,
beyond which continued growth cannot proceed. Additional studies will be required
to confirm this hypothesis, identify the relevant factor(s), and clarify the role of cell
cycle staging on its effects.
Finally, our data suggests that the GRR parameter can be used to relate the
short- and long-term effects of drug exposure on a cell’s fate. Based on these data,
we hypothesize that it may be possible to rapidly identify drugs which impair cell
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growth and proliferation using the instantaneous GRR, an accessible quantity that
can be empirically determined from a single cell in less than an hour. We are cur-
rently performing studies using a diverse set of drugs to confirm the generality of this
relationship. In the future, we anticipate that MMASS may enable the rapid identi-
fication of effective anticancer drugs in cell lines and patient-derived tumor cells.
4.5 Material and Methods
Mouse Lymphoblast Culture and Growth Medium. L1210 mouse lympho-
cytic leukemia cells were cultured and measured in Lebovitz’s L15 medium (Invit-
rogen 21083027) supplemented with 0.4% (wt/vol) glucose (Sigma-Aldrich G8769),
10% (wt/vol) fetal bovine serum (Invitrogen 16000-044), and 1% (wt/vol) penicillin
streptomycin mix (Cellgro MT-30-002-CI). The cells were grown inside tissue culture
flasks at 37◦C and at an ambient 5% carbon dioxide. The culture was kept in log
phase by periodically taking an aliquot of cells and re-suspending it into fresh medium
every 48 hours. Cell count was maintained between 50 x 103 mL−1 and 200 x 103
mL−1. Single-cell growth conditions inside the SMR emulated that of the culture
(L15+FBS+glucose+penstrep medium and 37◦C).
For drug response measurements, the growth medium was additionally supple-
mented with the drug of interest. The final concentrations are listed in the follow-
ing: 250nM Torin1 (provided by N.S. Gray, Dana-Farber Cancer Institute), 3 µM
staurosporine (Sigma-Aldrich S6942), and 5 µg mL−1 cycloheximide (Calbiochem
239763). The drugs were dissolved in DMSO (Sigma-Aldrich 472301).
Priming the Microfluidic System. A schematic of the microfluidics is illustrated
in Supplementary Figure 4-1. The SMR device consisted of two larger bypass channels
connected by a buried channel (15 x 20 µm in cross-section) embedded in a mass-
sensing silicon cantilever (SMR). The bypass channels provided two independent flow
paths from a single upstream sample vial to the downstream waste vials. A portion of
the fluid content from either bypass could be diverted through the SMR to the other
by applying a pressure differential across the buried channel. In a typical experiment,
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the three glass vials were pressurized by two computer-controlled pressure regulators
(Proportion Air) which were multiplexed by solenoid valves (SMC) to generate three
distinct pressure levels: atmosphere (atm), P, P-∆P. Supplementary Figure 4-1A
shows that the first step in any experiment was filling the channels and fluidics with
growth media. At a pressure differential of 15 psi between upstream and downstream,
it took less than two minutes for the entire system to be primed.
Sample Loading. Supplementary Figure 4-1B,C illustrates a technique we employed
for sample loading to ensure that only a single cell was monitored by the system. One
of the two downstream vials containing 1 mL of water was replaced with 1 mL of cell
sample (25 x 103 counts). Positive gauge pressure P = 8 psi was applied on both the
upstream sample vial (containing growth medium) and the downstream sample vial
(containing cells). The remaining waste vial was kept at atmospheric pressure, or 0
psi gauge pressure. In this configuration, pinch flow in one bypass channel forced the
upstream media and the downstream cells to converge upon entry into the SMR. On
the other bypass, there was a constant flow of media from sample to waste. When a
cell transit was sensed by the SMR, the gauge pressure on the waste vial was raised
8 psi to balance the pressure and to achieve stop flow. At the flow rates and cell
concentration described here, cell loading took approximately 2-3 minutes.
Dynamic Trapping. Once a cell was loaded, the upstream sample vial was replaced
with one containing 1mL of media supplemented with the drug of interest, and the
downstream cell sample was replaced with 1mL of water (Supplementary Figure 4-
1D). The heights of all the vials were also adjusted accordingly so that the cell remains
stationary within the bypass channel during stop flow. Keeping the fluids at the
same volume and balancing the vial heights prevented unwarranted gravitational
leakage flow. Supplementary Figure 4-1E,F demonstrates how a single cell was kept
within the system and how additional cells were flushed out. The process involved
keeping the upstream sample vial at a positive gauge pressure of P = 2.5 psi while
the downstream waste vials alternated between P = 0 and P = 2.5 psi. Dynamic
trapping software written in NI Labview 10.0 was used to sense cell transit upon
which, the computer actuated the solenoid valves to alternate the pressure settings.
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With every iterative reverse flow, the cells were brought out deep into the bypass.
Additional cells loaded in the system were flushed out into the waste. Simultaneously,
growth media supplemented with a drug began loading into a reservoir upstream of
the bypass channels.
During growth monitoring, the flow rate across the SMR was reduced substantially
as the pressure in the waste vials alternated between P- ∆P = 2.3 psi and P = 2.5 psi.
The transit time of a cell through the cantilever was approximately 100 milliseconds.
Every flow reversal event (triggered by a cell transit through the SMR) was preceded
by 1-2 minutes of stop flow where the cell was held within the large bypass channels. In
long-term dynamic trapping, the system cycled through the sequence beginning with
Supplementary Figure 4-1G. When the cell passed through the SMR and entered the
left bypass, the system proceeded to stop flow, or cell storage, (Supplementary Figure
4-1H) for 1-2 minutes. This was followed by a flow reversal event (Supplementary
Figure 4-1I). Upon completion of the cell transit in Supplementary Figure 4-1I, the
system entered another stop flow (not shown), or cell storage in the right bypass, and
then returned to the configuration in Supplementary Figure 4-1G for a new cycle.
Lengthening the interval between mass measurements reduced the collective shear
stress on the cell from frequent transits through the SMR and was essential to the
cell’s long-term survival.
Because the fluid entering the SMR from upstream and downstream was pinched
at each flow reversal step (Supplementary Figure 4-1G, 4-1I), the cell was hydrody-
namically focused to either the inner or outer wall of the embedded channel. Fluid
flow within the SMR is viscous dominated, so the cell’s path was confined the entire
way during traversal. Hydrodynamic focusing has been shown to reduce the mea-
surement error of a mammalian cell’s buoyant mass in the SMR down to as low as
0.05% in standard deviation (Son et al., 2012).
Fluid Switching. The process of evolving a cell’s surrounding from growth media
to growth media carrying a drug involved the successive forwarding of fluid from
the upstream reservoir while simultaneously re-suspending the cell into a gradually
changing environment as shown in Figure 4-1A-F. The dynamic trapping software
89
utilized time derivative of SMR frequency to detect cell transit. Cells could be trapped
in fluids of various densities enabling the use of a density tag to indicate the entry of
a new fluid into the SMR. Prior to each experiment, a density tag was introduced on
the media carrying the drug by evaporating ∼1% of its water content.
The pressure settings used for fluid forwarding (or drug delivery) were the same
as those described in Supplementary Figure 4-1E,F for flushing out excess cells in
the bypass and for loading new fluid into the upstream reservoir (upstream sample
vial is kept at a positive gauge pressure of P = 2.5 psi while the downstream waste
vials alternated between P = 0 and P = 2.5 psi). At these pressure differentials, cells
were brought out deep into the bypass channel on the downstream side resulting in
tens of nanoliters of new fluid entering the system per iteration. The number of cell
transits per minute is increased by ten to twenty times and the transit duration across
the SMR is reduced ten folds from 100 milliseconds to 10 milliseconds. The entire
exchange was completed in less than 5 minutes.
Leucine Incorporation Assay. Four culture flasks were used, each containing one
of the following: DMSO (2 µL mL−1), Torin1 (250 nM), STS (3 µM), and CHX (5
µg mL−1). At t=0, 5 µCi mL−1 3H-leucine (American Radiolabeled Chemicals) was
added to each culture flask along with drugs at the concentrations listed above. At the
indicated time points (2, 5, and 20 h), cell suspensions were pelleted by centrifugation
and media was removed by aspiration. Cells were washed twice with ice cold PBS.
Cells were then resuspended in 1 mL of ice cold 10% trichloroacetic acid (TCA)
in H2O and incubated at 4◦C for 30 min. Precipitates were then washed with ice
cold PBS and dissolved with 0.5 M NaOH at room temperature (1 mL). Leucine
incorporation was determined by scintillation counting of the resulting solution.
Coulter Counter Volumetric Measurements. 72-hour time-lapsed cell count
measurements were taken on the Multisizer 4 Coulter Counter for four culture flasks
each containing the same contents as that listed in the leucine incorporation assay.
At t=0, the drug of choice was added into the culture flask and an aliquot of the cells
was measured to determine initial cell concentration. Thereafter, the measurements
were repeated at t=2, 5, 10, 20, 42, and 72 hours.
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Data Processing. The buoyant mass versus time presented here was derived by
smoothing raw data with a 30-minute moving average. For growth rate versus mass, a
point-by-point derivative was taken on the smoothened data. An additional 30-minute
time window was applied to smooth the results of the growth rate calculation. For
GRR computation, 30-minute windows of raw data before and after drug delivery were
fitted with linear curves. The time to no growth from drug delivery was calculated
based on the following criterions: 1) the average growth rate had to be at most 10-fold
less than that prior to drug treatment; 2) the growth of the cell cannot be more than
1% of its total growth from birth after the determined time point.
Error Calculation. The error was calculated from analyzing the raw data of a cell
trapped for over ten hours with no apparent growth. The standard deviation of the
raw data over a 30-minute window was used to estimate the error bar for buoyant mass
versus time. Supplementary Figure 4-6A shows a red line representing the average
mass across a 30-minute window superimposed on the raw data. Supplementary
Figure 4-6B shows a histogram of the data in Supplementary Figure 4-6A with a
Gaussian fit. The measurement error across a 30-minute window was determined to
be approximately 0.14% of the cell’s mass in standard deviation. Growth rates over
the entire 12-hour window were then calculated by a 30-minute sliding window linear
fit. In a cell without appreciable growth, the growth rate should be centered about
zero pg hr-1. Therefore, a good estimate of the error would be the maximum and
minimum growth rate over the 12-hour window (Supplementary Figure 4-6C).
System Calibration. Polystyrene beads from Bangs Labs NT27N (10 µm) with a
known density and a standardized volume were measured by the SMR to generate
a histogram of resonant frequency shifts. The mass of a polystyrene bead (density
x volume) was divided by the average resonant frequency shift to determine the
calibration factor (pg hz−1).
91
4.6 Acknowledgements
We thank the Kirschner lab at Harvard Medical School for providing the L1210 mouse
lymphocytic leukemia cell lines and the knowledge regarding cell culture. This re-
search was funded by the Institute of Collaborative Biotechnologies through con-
tract no. W911NF-09-D-0001 from the US Army Research Office and the National
Cancer Institute contracts R21 CA137695 and Physical Sciences Oncology Center
U54CA143874. Y.W. acknowledges support through an NSF graduate fellowship.
K.C.W. is the recipient of a NIH Ruth L. Kirschstein National Research Service
Award and a Misrock Fund Postdoctoral Fellowship through the Koch Institute for
Integrative Cancer Research at MIT. S.S. is supported by a graduate fellowship from
KEF, South Korea.
4.7 References
B. B. Aldridge, M. Fernandez-Suarez, D. Heller, V. Ambravaneswaran, D. Irimia,
M. Toner, and S. M. Fortune. Asymmetry and aging of mycobacterial cells lead
to variable growth and antibiotic susceptibility. Science, 335(6064):100 –104, Jan.
2012. doi: 10.1126/science.1216166.
N. Q. Balaban, J. Merrin, R. Chait, L. Kowalik, and S. Leibler. Bacterial persistence
as a phenotypic switch. Science (New York, N.Y.), 305(5690):1622–1625, Sept.
2004. ISSN 1095-9203. doi: 10.1126/science.1099390. PMID: 15308767.
B. S. Baliga, A. W. Pronczuk, and H. N. Munro. Mechanism of cycloheximide inhibi-
tion of protein synthesis in a cell-free system prepared from rat liver. The Journal
of Biological Chemistry, 244(16):4480–4489, Aug. 1969. ISSN 0021-9258. PMID:
5806588.
C. A. Belmokhtar, J. Hillion, and E. Sgal-Bendirdjian. Staurosporine induces apopto-
sis through both caspase-dependent and caspase-independent mechanisms. Onco-
gene, 20(26):3354–3362, June 2001. ISSN 0950-9232. doi: 10.1038/sj.onc.1204436.
PMID: 11423986.
C. D. Bortner and J. A. Cidlowski. Apoptotic volume decrease and the incredible
shrinking cell. Cell Death and Differentiation, 9(12):1307–1310, Dec. 2002. ISSN
1350-9047. doi: 10.1038/sj.cdd.4401126. PMID: 12478467.
92
T. P. Burg, M. Godin, S. M. Knudsen, W. Shen, G. Carlson, J. S. Foster, K. Babcock,
and S. R. Manalis. Weighing of biomolecules, single cells and single nanoparticles in
fluid. Nature, 446(7139):1066–1069, Apr. 2007. ISSN 0028-0836. doi: 10.1038/na-
ture05741.
H. G. DAVIES and M. H. F. WILKINS. Interference microscopy and mass determi-
nation. Nature, 169(4300):541, Mar. 1952. doi: 10.1038/169541a0.
M. Godin, F. F. Delgado, S. Son, W. H. Grover, A. K. Bryan, A. Tzur, P. Jorgensen,
K. Payer, A. D. Grossman, M. W. Kirschner, and S. R. Manalis. Using buoyant
mass to measure the growth of single cells. Nat Meth, 7(5):387–390, May 2010.
ISSN 1548-7091. doi: 10.1038/nmeth.1452.
W. H. Grover, A. K. Bryan, M. Diez-Silva, S. Suresh, J. M. Higgins, and S. R.
Manalis. Measuring single-cell density. Proceedings of the National Academy of
Sciences, June 2011. doi: 10.1073/pnas.1104651108.
D. A. Guertin and D. M. Sabatini. Defining the role of mTOR in cancer. Cancer
Cell, 12(1):9–22, July 2007. ISSN 1535-6108. doi: 10.1016/j.ccr.2007.05.008. PMID:
17613433.
D. A. Guertin and D. M. Sabatini. The pharmacology of mTOR inhibition. Sci.
Signal., 2(67):pe24, Apr. 2009. doi: 10.1126/scisignal.267pe24.
V. Lecault, M. VanInsberghe, S. Sekulovic, D. J. H. F. Knapp, S. Wohrer, W. Bowden,
F. Viel, T. McLaughlin, A. Jarandehei, M. Miller, D. Falconnet, A. K. White,
D. G. Kent, M. R. Copley, F. Taghipour, C. J. Eaves, R. K. Humphries, J. M.
Piret, and C. L. Hansen. High-throughput analysis of single hematopoietic stem
cell proliferation in microfluidic cell culture arrays. Nat Meth, 8(7):581–586, July
2011. ISSN 1548-7091. doi: 10.1038/nmeth.1614.
Q. Liu, J. W. Chang, J. Wang, S. A. Kang, C. C. Thoreen, A. Markhard,
W. Hur, J. Zhang, T. Sim, D. M. Sabatini, and N. S. Gray. Dis-
covery of 1-(4-(4-Propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-
3-yl)benzo[h][1,6]naphthyridin-2(1H)-one as a highly potent, selective mammalian
target of rapamycin (mTOR) inhibitor for the treatment of cancer. J. Med. Chem.,
53(19):7146–7155, 2010. ISSN 0022-2623. doi: 10.1021/jm101144f.
r. Rauscher, F and E. Cadman. Biochemical and cytokinetic modulation of l1210
and HL-60 cells by hydroxyurea and effect on 1-beta-D-arabinofuranosylcytosine
metabolism and cytotoxicity. Cancer Research, 43(6):2688–2693, June 1983. ISSN
0008-5472. PMID: 6189585.
J. Reed, J. Chun, T. Zangle, S. Kalim, J. Hong, S. Pefley, X. Zheng, J. Gimzewski,
and M. Teitell. Rapid, massively parallel Single-Cell drug response measurements
via live cell interferometry. Biophysical Journal, 101(5):1025–1031, Sept. 2011.
ISSN 0006-3495. doi: 10.1016/j.bpj.2011.07.022.
93
D. D. Sarbassov, S. M. Ali, and D. M. Sabatini. Growing roles for the mTOR pathway.
Current Opinion in Cell Biology, 17(6):596–603, Dec. 2005. ISSN 0955-0674. doi:
10.1016/j.ceb.2005.09.009. PMID: 16226444.
S. Son, A. Tzur, Y. Weng, P. Jorgensen, M. W. Kirschner, and S. R. Manalis. Di-
rect observation of cell growth and size regulation in mammalian cell. submitted
manuscript., Jan. 2012.
C. C. Thoreen, S. A. Kang, J. W. Chang, Q. Liu, J. Zhang, Y. Gao, L. J. Reichling,
T. Sim, D. M. Sabatini, and N. S. Gray. An ATP-competitive mammalian target of
rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. Journal of
Biological Chemistry, 284(12):8023–8032, Mar. 2009. ISSN 0021-9258, 1083-351X.
doi: 10.1074/jbc.M900301200.
A. Tzur, R. Kafri, V. S. LeBleu, G. Lahav, and M. W. Kirschner. Cell growth and
size homeostasis in proliferating animal cells. Science, 325(5937):167 –171, July
2009. doi: 10.1126/science.1174294.
Y. Weng, F. F. Delgado, S. Son, T. P. Burg, S. C. Wasserman, and S. R. Manalis.
Mass sensors with mechanical traps for weighing single cells in different fluids. Lab
on a Chip, 11(24):4174, 2011. ISSN 1473-0197, 1473-0189. doi: 10.1039/c1lc20736a.
94
4.8 Figures
Figure 4-1: The progression of fluid exchange in the channel and drug delivery to the cell Is
illustrated (left: sensor readout; right: the corresponding state of the SMR device). At the interface
between media (blue) and media with drug (red), there is a minor amount of mixed fluid (purple)
that is flushed out during drug delivery. A) cell is in growth media only. B) peak corresponds to cell
passing through the sensor. C,D) cell is suspended into new media and sensor baseline frequency
shifts as channel is filled with media containing diffuse drug. E,F) cell is suspended into new media
and sensor baseline frequency shifts as channel is filled with growth containing the drug at full
concentration.
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Figure 4-2: A) The mass accumulation of a cell grown in growth media exchanged into growth
media. New growth media delivery occurred at the time point where the blue backdrop becomes
red. The mass versus time of a single progeny from subsequent generations are also shown. B)
The growth rate versus size of each cell generation shown in A; gray shading represents the growth
rate of 12 untreated cells; asterisk (*) denotes fluidic exchange. C) Growth response of single cells
in the same lineage to mTOR inhibition. Black and red represents cells that grew in pure media.
Treatment with 250 nM took place in early green. D) Growth rate versus size of (C). E) Growth
response of a single cell treated with 3µM STS. F) Growth rate versus mass of (E). G) Growth
response of a single cell treated with 5µg mL-1 CHX. H) Growth rate versus mass of (G).
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Figure 4-3: A) Cumulative time following drug treatment required for a cell to reach minimal or
no growth versus GRR, the ratio that compares the instantaneous growth rate after to that before
drug delivery. B) Leucine incorporation assay performed on bulk cultures treated with vehicle
(DMSO), Torin1, STS, or CHX to obtain population growth rates. C) Proliferation assay by cell
count following drug treatment.
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4.9 Supplementary Figures
Supplementary Figure 4-1: Schematic of MMASS fluidics. Upstream source vial is referred to
as S1, downstream left vial is referred to as L2, and downstream right vial is referred to as R3. A)
Priming step: contents of S1 are flushed through both bypasses to the L2 and R3. B) Cell loading
step: L1 (containing waste) is replaced with cell sample. Pressure (P) applied on L2 and S1. C)
Cell loading is complete after a single cell passes through the SMR from the left to the right bypass;
pressure on all vial is set to atmosphere (atm). D) S1 (containing media) is replaced with another
(containing media + drug). L2 is replaced with waste vial. At this point, all vials contain the same
amount of fluid; heights of vial are adjusted to ensure that there is no leakage flow due to gravity
during stop flow. E) Pressure (P) is applied to S1 and R3 to reverse flow enabling the cell in the
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right bypass to pass through the SMR into the left bypass. F) Pressure (P) is applied to the S1 and
L2 to reverse flow enabling the cell to return to the right bypass. Steps (E) and (F) flush out any
extra cells loaded into the system and are also used during drug delivery while keeping a single cell
trapped. G) Pressure (P) is applied to S1 and L2, and a smaller pressure (P-∆P) is applied to R3.
This reverses the flow to bring the cell back through the SMR again. H) After the cell arrives at left
bypass, pressure (P) is applied to all vials to ensure stop flow. Cell is stored here for a designated
amount of time. I) Another flow reversal event occurs (P to S1 and R3, P-∆P to L2) to bring the
cell back through the SMR and is followed by another cell storage step (P to all vials) once it arrives
at the right bypass. Steps (G), (H), and (I) describe the fluidic manipulation for long-term dynamic
trapping.
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Supplementary Figure 4-2: A) Mass versus time of cells growing in media. B) Growth rate
versus time of untreated cells. C,D,E) As a comparison to on-chip treated cells, growth trajectories
of cells pre-treated with Torin1 (250 nM) are reported here.
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Supplementary Figure 4-3: Growth trajectories of individual cells before and after treatment
with Torin1 (250 nM). Light blue indicates cell growing in media and red indicates cell treated with
drug.
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Supplementary Figure 4-4: Growth trajectories of individual cells before and after treatment
with STS (3 µM). Light blue indicates cell growing in media and red indicates cell treated with
drug.
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Supplementary Figure 4-5: Growth trajectories of individual cells before and after treatment
with CHX (5 µg mL−1). Light blue indicates cell growing in media and red indicates cell treated
with drug.
103
Supplementary Figure 4-6: Error analysis for the method. (A) thirty-minute trace of a trapped
cell with no growth. (B) Gaussian fit on a histogram generated from repeated measurements of the
same cell for thirty-minutes. (C) Buoyant mass and growth rate versus time plot of a trapped cell
with no growth for 10 hours. The max and min of each serve as a good indication of error.
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Chapter 5
Conclusions
We approached the problem of understanding mammalian cellular behavior after drug
intervention by tracking the growth and proliferation of individual cells. To monitor
growth, we utilized the SMR mass sensor to measure the buoyant mass of cells with
unparalleled precision. However, previous implementations of the SMR instrument
can only record the mass of a cell once, i.e., in a flow through manner, but the process
of quantifying mass accumulation requires multiple measurements of an individual
cell.
We employed various single-cell manipulation techniques to enable both time-lapse
measurements with the SMR and on-chip fluid exchange for drug delivery. After
several iterations of instrument design, we developed the MMASS, a method that
takes full advantage of laminar flow in the SMR device to allow periodic cell storage,
repetitive mass measurements, and on-demand drug treatment. In addition to the
femtogram level mass resolution of the SMR, what sets MMASS apart from other
instruments in this area of research is its ability to investigate one or more generation
of mammalian cell growth both before and after drug treatment. By measuring the
same cell in both its native and its perturbed state, the method can make a fair
comparison between a cell’s normal behavior and its response to a drug therapy.
Although MMASS can perform its functions reliably without incidents of losing
a cell during an experiment, a limitation to the method is that one system can only
monitor one cell at a time. This can become extremely time-consuming if we are
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trying to discover the behavior of rare or unusual cells in a population. Nevertheless,
techniques to increase throughput are currently under development. For example, a
new type of device, known as the serial SMR (or sSMR), contains a longer buried
channel that can multiplex between a low number of cells (N < 10) at any given time.
The sSMR can also study the growth dynamics of both daughter cells after a division
event. In addition, we are also in the process of designing new devices which will
contain anywhere between 100 to 1000 SMRs per chip.
Simultaneously, we are expanding into the area of translational research by seek-
ing out clinical applications for MMASS. One unmet need for which the instrument
can serve to fulfill is in the optimization of a personalized combinational therapy
for cancer patients before or after surgery. At present, the treatment regimen is a
standard course of radiation or chemotherapy based solely on the tumor’s pathol-
ogy. By screening the potency of drugs on individual cells taken from a biopsy or
the patient’s resected tumor, MMASS can pinpoint effective therapies against cells of
varying genotypes. The results can then help a physician arrive at better treatment
strategies to decrease the risk of metastases and improve a patient’s quality of life by
preemptively eliminating ineffective treatment options in vitro.
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Appendix A
Drive and multiplier circuit
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Figure A-1: The drive circuit optimizes the periodic signal from the photodetector board by
amplifying and phase shifting it. The multiplier circuit convolves the periodic signal with a pure
sine wave and filters for the lower frequency component, thereby resulting in a sinusoid with a
frequency equivalent to the difference of the two input signals.
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Deriving Fluid Velocity Profile Within the SMR
Navier-Stokes equation in Cartesian coordinates:
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+
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]
(B.1)
Inertial term is neglected because the flow is steady and fully developed without
swirls.
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(B.2)
Suppose a cross section of the channel in the x-y plane yields a dimension of Lx x
Ly. A solution of the form
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would yield 0 at x = −Lx
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because there is no-slip, or no flow,
at the walls. Evaluating the RHS of (B.2) with (B.3), we get
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Taking the Fourier series integral on both sides of (B.4) yields
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By the principle of orthogonality, the double sum collapses down to
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lpi
Ly
)2]
ak,lcos
2
(
kpi
Lx
x
)
cos2
(
lpi
Ly
y
)
dxdy (B.5)
Evaluating the integral on both sides and solving for the Fourier series coefficient
ak,l, we find the solution
Vz(x, y) =
∑
k=odd
∑
l=odd
ak,lcos
(
kpi
Lx
x
)(
lpi
Ly
y
)
(B.6)
where,
ak,l =
16
klpi2
1
µ
dP
dz
[
−
(
kpi
Lx
)2
−
(
lpi
Ly
)2]−1
sin
(
kpi
2
)
sin
(
lpi
2
)
(B.7)
For all even values of k and l, ak,l=0. As a check to see if equation (B.6) is the
complete solution, we evaluate the following solution into the RHS of (B.2)
Vz(x, y) =
∞∑
m=1
∞∑
n=1
bm,nsin
(
mpi
Lx
x
)
sin
(
npi
Ly
y
)
Taking the Fourier sine series integral for the LHS of (B.2), we get
∫ Lx
2
−Lx
2
∫ Ly
2
−Ly
2
1
µ
dP
dz
sin
(
kpi
Lx
x
)
sin
(
lpi
Ly
y
)
dxdy = 0
Thus, all coefficients for the Fourier sine series, bm,n, equal 0. Next we compute the
average fluid velocity Vavg numerically.
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1LxLy
∫ ∫
A
Vz(x, y) dxdy =
[
1
LxLy
Lx
2∑
x=−Lx
2
Ly
2∑
y=
−Ly
2
V (x, y)
dP/dz
∆x∆y
]
dP
dz
= v˜
dP
dz
(B.8)
We can relate pressure drop to flow rate,
Q = AVavg = Av˜
dP
dz
(B.9)
where A = LxLy, v˜ is computed numerically by (B.8), and
dP
dz
∼ ∆P
∆z
across the SMR.
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Displacement of micron-sized objects due to SMR oscillation
We want to calculate the displacement of nanometer to micron-sized objects due to
SMR oscillation in the y-axis. The oscillation of the SMR and the fluid within is
given by
y(t) = Acos(ωt)
where A is the amplitude of oscillation and ω is the frequency of oscillation in
radians.
v(t) =
dy(t)
dt
= −Aωsin(ωt)
Applying Stoke’s law, we find that the drag force on an object is
F = ma = 6piµr
[
Vfluid − vp
]
(B.10a)
dvp
dt
=
6piµr
ρ4
3
pir3
[− Aωsin(ωt)− vp] (B.10b)
Let Φ be defined as the constant 6µ
ρ 4
3
r2
where r is the radius of the object, ρ is the
density difference between the cell and the fluid medium, and µ is the viscosity of the
fluid. Alternatively, we can define Φ as 6µr
mb
, a ratio of viscosity to buoyant mass. We
rewrite equation (B.10b) as a first order differential equation
dvp
dt
+ Φvp = −ΦAωsin(ωt) (B.11)
The general solution to equation (B.11) is
vp = c1exp(−Φt) (B.12)
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The particular solution to equation (B.11) is
vp = c2cos(ωt) + c3sin(ωt) (B.13)
Evaluating the LHS of equation (B.11) with equation (B.13), we get
(c3ω + Φc2)cos(ωt) + (Φc3 − c2ω)sin(ωt) = −ΦAωsin(ωt)
c2 =
ΦAω2
ω2 + Φ2
(B.14)
c3 =
−ΦA2ω
ω2 + Φ2
(B.15)
We superimpose the general (B.12) and particular (B.13) solutions and evaluate
(B.14) and (B.15) into (B.13).
vp = c1exp(−Φt) + ΦAω
2
ω2 + Φ2
cos(ωt)− ΦA
2ω
ω2 + Φ2
sin(ωt)
Applying the boundary condition vp = 0 at t = 0, we obtain the complete solution
for an object’s oscillation velocity within the SMR.
vp = − ΦAω
2
ω2 + Φ2
exp(−Φt) + ΦAω
2
ω2 + Φ2
cos(ωt)− Φ
2Aω
ω2 + Φ2
sin(ωt) (B.16)
where Φ = 6µr
mb
. To find the displacement of the object in the y-axis, we take the
following integral and evaluate the boundary condition yp = A at t = 0.
yp =
∫
vpdt =
A
ω2 + Φ2
[
ω2exp(−Φt) + Φωsin(ωt) + Φ2cos(ωt)
]
(B.17)
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Centrifugal force on an object from the SMR’s oscillation
An object near the SMR apex will experience a centrifugal force due to the cantilever’s
oscillation. To express this analytically, we employ the following equation:
Fc = ρ
4
3
pir3
vp
2
L
(C.1)
where ρ4
3
pir3 is the buoyant mass of the object with radius r, ρ is the density difference
between the object and the fluid medium, vp is the velocity of oscillation given in
(B.16), and L is the length of the cantilever. We can further solve for the velocity,
vc, of the object in the outward direction by a force balance between the centrifugal
force (C.1) and Stoke’s law.
vc =
2
9
ρr2
µ
vp
2
L
(C.2)
Next, since vp is periodic and time-dependent, we integrate (C.1) and (C.2) over an
entire oscillation period T , where T = 2pi
ω
. Because we are assuming steady state, the
exponential (transient) term from (B.16) is ignored.
Fc =
1
L
[
ρ
4
3
pir3
][ 1
T
∫ T
0
vp
2dt
]
=
1
2L
[
ρ
4
3
pir3
][( ΦAω2
ω2 + Φ2
)2
+
(
Φ2Aω
ω2 + Φ2
)2]
(C.3)
vc =
2
9
ρr2
µL
[
1
T
∫ T
0
vp
2dt
]
=
1
9
ρr2
µL
[(
ΦAω2
ω2 + Φ2
)2
+
(
Φ2Aω
ω2 + Φ2
)2]
(C.4)
Evaluating the integral, we get the average centrifugal force, Fc, applied on an object
near the apex of the SMR and the average velocity, vc, of the object in the outward
direction due to the cantilever’s oscillation.
On a 15x20 µm cantilever, electrostatic actuation will result in an oscillation
amplitude equivalent to tens of nanometers, an amount too small for any centrifugal
force to be realized. To achieve an oscillation amplitude above ∼100 nm where the
effects of the centrifugal force are substantial, we require the use of a piezoelectric
crystal for actuation. Figure C-1A plots the average centrifugal acceleration on a
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10 µm object versus a range of ρ, a good indication of buoyant mass, mb, for three
different viscosities. Figure C-1B plots the average velocity on a 10 µm object versus
ρ for the same viscosities. Both plots assume a cantilever oscillation amplitude of 200
nm.
According to Figure C-1A, for a given viscosity the object will experience the
greatest centrifugal acceleration when it has a low mb. As discussed in chapter 3,
an object with little or no inertial effect will follow the oscillation of the cantilever
exactly and will thus experience the maximum average centrifugal acceleration. As mb
increases, the object’s inertial effects reduce its amplitude of oscillation and thereby
decrease the average outward acceleration. As the viscosity of the fluid increases,
the object’s inertial effects are increasingly mitigated by the fluidic resistance. This
causes the object’s amplitude of oscillation to approach that of the cantilever. Thus,
for a given mb, the object will experience a greater acceleration at a higher fluid
viscosity.
According to Figure C-1B, an object with mb=0 does not move. It is essentially
weightless and does not feel a force regardless of the acceleration applied. As the mb
of an object increases from zero, the velocity will initially increase. However, at some
threshold mb the inertial effects of the object takes over and any increase in mass will
substantially decrease velocity. An increase in viscosity will increase the mb threshold
required for inertial effects of the object to become substantial. As an extreme case of
high viscosity (black curve), the object’s outward velocity remains low for a given mb
despite a large acceleration as seen in Figure B-1. This is because the fluid viscosity
is hindering the object from moving outward quickly.
Based on the predicted values in Figure C-1B, a polystyrene bead ρ = 1.05 g cm−3
in water would have an average velocity of ∼26 µm s−1. As we had determined em-
pirically, it would be able to move into the column traps at the apex of the cantilever
well within 1 s.
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Figure C-1: A) Average centrifugal acceleration (m s−2) versus ρ for a 10 µm object in three
different viscosities. B) Average outward velocity (µm s−1) versus ρ for a 10 µm object in three
different viscosities.
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